top ad
Post Subject Author Posted On
1180 NetworkNewsBreaks – Eco-friendly Lithium Needs Fuel 92 Resources Corp. (TSX.V: NTY) (OTCQB: RGDCF) (FSE: R9G2) Projects As a growing number of countries pass legislation that builds on social change in the urban transportation arena, 92 Resources (TSX.V: NTY) (OTCQB: RGDCF) (FSE: R9G2) is working to deliver emerging tech-friendly solutions in the form of lithium for next-generation batteries. An article discussing this reads, “Electric vehicles powered by lithium and cobalt batteries have proven particularly attractive to markets within metropolitan areas, where gasoline’s advantages involving longer travel distances and established refueling networks are less critical. And automakers have taken notice, with many of them now committed to release a lineup of all-electric vehicles or hybrids with electrical plug-in capabilities during the coming years.” Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: networknewswire 11/17/2017 05:12:11 PM
1179 NetworkNewsBreaks – Online Travel Services Rediscover Human Touch Through Cache Elite Inc.’s (ILUS) TripWitz Cache Elite (OTC: ILUS) has built an online travel service, TripWitz, that breaks the mold of the impersonal and less user-friendly self-customizing trip-booking experience that has become commonplace throughout the industry in recent years. In the process, it helps would-be travelers eliminate many of the frustrations that accompany efforts to create an ideal getaway from the daily routine. An article discussing this reads: “Cache Elite Inc. (OTC: ILUS) launched an online travel service, TripWitz, offering access to free assistance from live travel agents. Travelers are now able to combine the convenience of online travel booking with human interaction from travel experts to answer queries and help with vacation planning. … TripWitz offers travelers a portal to access real-time information on tour packages, fares, accommodation and destination activities. In addition, they can enlist the help of travel agents at no charge to find deals at the best prices and to make reservations. TripWitz uses Google’s ITA Gateway software to connect to global airlines, which enables it to provide immediate data on fares, flight schedules and seat availability. The company is now accepting Bitcoin as payment mechanism for their travel services.” Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: networknewswire 11/17/2017 05:07:22 PM
1178 NetworkNewsBreaks – Why Medical Cannabis Payment Solutions (REFG) is “One to Watch” Anyone familiar with the legal cannabis markets knows one of the most critical bottlenecks is payment and payment processing. Medical Cannabis Payment Solutions (OTC: REFG) is intent on opening the bottleneck with its proprietary merchant processing system designed to serve the monetary demands of the state-legalized cannabis market. A recent article provides an overview of what may be the next big thing in the marijuana business. The article says that, “Medical Cannabis Payment Solutions (OTC: REFG), headquartered in Cheyenne, Wyoming, is a first-tier merchant processing cannabis industry pioneer, offering one of the first and only comprehensive card processing operations of its kind to serve the state-sanctioned medical marijuana industry. The company’s state of the art system, which also tracks sales and tax collection, and eliminates the need to deal in cash-only transactions.” Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: networknewswire 11/17/2017 05:04:24 PM
1177 NetworkNewsBreaks – Marijuana Company of America, Inc. (MCOA) Offers Portfolio of Promise in Cannabis and Hemp A diversified approach is often the best path to investment success, especially in the burgeoning cannabis and hemp markets. With a portfolio of operating subsidiaries, partnerships and joint ventures, Marijuana Company of America (OTC: MCOA) offers investors broad diversification guided by experienced and savvy management. More comprehensive information can be found in a recent article which states, “A new report from market analyst the Brightfield Group, featured in Forbes (, estimates that global sales of cannabis will climb to $31.4 billion by 2021. The U.S., which “currently drives 90 percent of global cannabis sales,” will dominate this international business. In turn, a large share of the U.S. cannabis market will undoubtedly go to one of the six biggest economies in the world, the state of California. Marijuana Company of America, Inc. (OTC: MCOA) is a publicly traded company that was established in 2015 in California by Don Steinberg and Charles Larsen to execute their vision of creating an umbrella over a diverse portfolio of cannabis- and hemp-based companies. MCOA has already established a commanding presence at various points in the cannabis and industrial hemp cannabidiol (CBD) markets, as well as related services supply chains.” Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: networknewswire 11/17/2017 05:00:55 PM
1176 NetworkNewsBreaks – AV1 Group, Inc. (AVOP) Noteworthy Amid Growing Cannabis Industry As a number of cannabis-related sectors prepare for what is expected to be exponential growth, AV1 Group (OTC: AVOP) is building its focus of identifying, securing and monetizing companies with emerging growth potential. An article discussing this reads: “AV1 Group explores every opportunity to help each sector exceed its revenue goals while building close, active working relationships as it prepares each respective division to be a robust competitor within the various chosen markets. … AV1 Group’s business model delivers an advantage with internally-created projects that are poised for revenue generation and a cross-company revenue platform that enables the company to incubate and foster growth in early-stage subsidiaries under one umbrella.” Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: networknewswire 11/17/2017 04:57:02 PM
1175 Rising Zinc Prices Drive Blue Moon Zinc Corp.’s (TSX.V: MOON) (OTC: BMOOF) Desire to Reopen Mine - Price of zinc rising amid demand for steel-galvanizing metal - Blue Moon’s California mine was productive during World War II - Site sits on 525 acres in Sierra Nevada Mountains Blue Moon Zinc Corp. (TSX.V: MOON) (OTC: BMOOF) believes it can take advantage of a rare opportunity to enter the resource-hungry zinc metal market by reopening a once-productive zinc mine in California’s gold country. The company considers it likely that the advanced-stage, 100 percent-owned Blue Moon zinc project on 525 acres, in the Foothills Massive Sulphide Belt of the Sierra Nevada Mountains, will yield a significant ore deposit at the depths of the exploration, where small-scale mining took place during World War II. Soil anomalies near the mine foster hope that there are additional deposits to be found along strike of the zone. The possibility is an attractive one, given the market factors that drove the London zinc exchange to a decade-high price of more than $3,000 per metric ton in October and a nine-and-a-half-year high on the Shanghai Futures Exchange of more than $4,000 per metric ton. The principal factors causing a price jump is the low level of the mineral stockpile — the lowest in nearly a decade. For decades the low price of zinc led to the shuttering of projects like Blue Moon’s, but demand has spiraled upward during the past decade, led largely by consumers in China. A large driver for zinc demand is the metal’s use in galvanizing steel and iron ( An analysis by the International Lead and Zinc Study Group found that demand for zinc grew by 1.14 percent during the first five months of 2017, with mine output rising 6.3 percent and refined metal output up 0.4 percent, according to a report in Mining Weekly ( Usage of the refined metal in the United States fell in 2016 but then rebounded with a 19 percent climb, according to the report. The Blue Moon project will be mined underground. The company has a resource of some 3.7 million indicated tons of ore graded at 8.33 percent zinc equivalent, which could yield about 377 million pounds of the metal at that level and more than 4 million inferred tons more with a grade of 7.84 percent zinc equivalence. The Blue Moon project also boasts silver, gold, and copper as byproducts. Blue Moon has contracted a preliminary economic assessment of the project that should be completed during the first quarter of 2018. For more information, visit the company’s website at Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: networknewswire 11/17/2017 04:53:23 PM
1174 LottoGopher Holdings Inc. (OTCQB: LTTGF) (CSE: LOTO) (FRA: 2LG) Enhances ‘Fun and Games’ Factor of Playing the Lottery - LottoGopher service enables players to purchase and manage lottery tickets online - Group play option enhances odds of winning - Company is working on expansion plan to enter 22 additional states by the end of 2018 Lottery players no longer have to drive to a physical location, stand in line, pay cash and then keep track of lotto tickets, because LottoGopher Holdings Inc. (OTCQB: LTTGF) (CSE: LOTO) (FRA: 2LG) is revolutionizing the lottery market with its pioneering online lottery messenger service. This service enables lotto players to easily and conveniently choose their numbers, order tickets and manage them through an online platform. Tickets can be purchased using debit and credit cards (bitcoin and Ethereum will soon be options, as well), eliminating the cash-only hassles currently faced by the majority of lottery players in the United States. In addition to these conveniences, LottoGopher is further adding an enjoyable social element for lottery participants, greatly enhancing the fun factor of playing the lotto. Through the social networking aspect of the Web-based LottoGopher service, players can network with other lottery participants to form game pools and play in groups—no longer bounded by physical distance or limited to one’s acquaintances only. This not only helps players improve their chances of winning but connects them to other lottery enthusiasts in a fun, social way. Here is the how LottoGopher’s social lottery service works: A player digitally orders Mega Millions, SuperLotto Plus or POWERBALL tickets for the same price they would pay in a store. Using the LottoGopher online platform, the player browses through ticket-pooling groups (which range in size from two to 100 members) or creates their own group. The player visits “My Account,” clicks “My Tickets” and then “Add to Group” to add selected tickets to the group pool. If one player in the group wins, every member shares the prize. LottoGopher additionally offers tips and strategies for increasing one’s odds of winning in a group, including finding “hot” groups that are winning frequently and finding “due” groups that are overdue for a large prize. The company further gives tips for amplifying one’s enjoyment of the group ticket-pooling process, including advising players to join a group with similar interests as them or playing with people in their own area. Currently, LottoGopher is only available to Californians, but the company is working diligently to expand its service to other states throughout the country, with plans to enter the lottery markets of more than 22 additional states by the end of 2018. As part of its expansion plan, the company is taking its model and applying it to the existing compliance structures of each individual target state. LottoGopher is fully compliant with lottery laws and regulations. First-time players checking out the service are offered a free initial ticket as an incentive to try it out. After this free play, they can buy one-day, one-month or one-year passes to use the site. For more information, visit the company’s website at Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: networknewswire 11/17/2017 04:49:13 PM
1173 92 Resources Corp. (TSX.V: NTY) (OTCQB: RGDCF) (FSE: R9G2) Explores Remote Reserves to Serve Urban Regions - Northwest Territories lithium project developing promising formations - Local government grant provides project cost options - Quebec property’s lithium potential may also help meet tech battery needs Canada’s secluded far north is energizing plans to provide urban societies in the earth’s more populated regions with eco-friendly travel options as automakers prepare for a new generation of technological advancements, and 92 Resources Corp. (TSX.V: NTY) (OTCQB: RGDCF) (FSE: R9G2) is exploring how to be part of the trend. The subarctic Northwest Territories early-stage mining project is developing four promising spodumene pegmatite geologic formations ( that are expected to prove lithium-bearing, thanks to scoping test work last year that achieved overall mineral extraction of 97 percent from concentrate ( The four formations that were sampled cross 2,080 meters and are among 60 channels sampled on the 1,849-hectare (4,569-acre) property north of Great Slave Lake’s shores. Crystals up to 36 inches long were reported. The project, dubbed the Hidden Lake Lithium Project, benefitted from a $140,000 government grant recognizing the property’s “highly ranked” potential under the Northwest Territories Mining Incentive Program in June ( Although Canada’s subarctic zone is remote from most populated centers, the Hidden Lake project has the advantage of being accessible from the Northwest Territories’ capital city some 40 km (25 miles) away. The company is also working to develop expected lithium reserves in Quebec and silica sand samplings in British Columbia. The Quebec exploration covers over 114,000 acres where 115 mineral claims are examining known large-crystal pegmatites outcroppings. Lithium has become an in-demand mineral resource as automakers begin working in earnest toward delivering electric vehicles powered by lithium and cobalt batteries. Current lithium supplies are expected to fall short of the rising demand, making new explorations an attractive venture. In addition to automotive uses, lithium-powered energy sources are being utilized for mobile phones and home computer applications. Industrial-sized lithium battery systems are also being put to work in some power infrastructures. “We have great exploration ahead of us at Hidden Lake. We are going to drill these things and try to build ore bodies. Hopefully it’s that easy,” Jody Dahrouge, a consultant and major shareholder in 92 Resources, said during an October 2017 interview ( “We’ve done a bit of metallurgical work already to make sure there are no insurmountable hurdles at this early stage. Everything looks extremely positive.” For more information, visit the company’s website at Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: networknewswire 11/17/2017 04:44:48 PM
1172 Cobalt Perfectly Positioned As Global Cobalt Demand Surges NetworkNewsWire Editorial Coverage: Cobalt, a metal somewhat overlooked by investors, is a critical component of lithium-ion batteries used in mobile devices and essential for the operation of electric vehicles (EVs). The spot price of cobalt has experienced an increase of 150 percent since the start of 2016, largely as a result of the exponential growth in the adoption of mobile technology in emerging economies. However, the real surge in global demand for cobalt will come from the automotive industry as more countries turn away from fossil fuel-driven cars to electric vehicles. To make the most of this surge in demand, Quantum Cobalt Corp. (CSE: QBOT) (FRA: 23B) is focusing efforts on developing its Canadian cobalt resources centered near Cobalt, Ontario. Quick Bullets: - China, Britain and France phasing out cars driven by fossil fuels in favor of alternatives - Electric vehicles predicted to be as affordable as cars running on gasoline by 2022 - Cobalt demand projected to surge from current 2,000 tons to 300,000 tons by 2030 - Cobalt price forecast to rise from $60,000 per ton to $100,000 per ton by 2030 The greatest demand for the metal is likely to come from China, currently the world’s top consumer of cobalt and its largest automotive industry. China recently announced a requirement that 20 percent of all cars sold by 2025 must operate on alternatives to fossil fuels. Britain and France have followed suit, declaring a ban on the sale of cars operating on fossil fuels by 2040 ( Tesla (NASDAQ: TSLA) is the leading manufacturer of EVs, making a significant contribution to the 2 million electrical vehicles on roads today. Other car manufacturers are scrambling to catch up. General Motors (NYSE: GM) has announced plans to launch a range of 20 EVs by 2023, while Volvo (OTC: VLVLY) is converting its technology to electric power by 2019. The VW Group (OTC: VLKAY) plans on investing $84 billion in car and battery production for the manufacture of 300 EV models by 2030. However, China will remain the world’s largest consumer and producer of EVs for the foreseeable future. Consumers there bought 507,000 EVs in 2016, an increase of 53 percent over the previous year. That’s double the sales in Europe and triple those sold in the U.S. From the current adoption rate of 1 percent of its automotive market, China is expected to see a 12 -fold increase in the number of EVs on its roads in five years’ time. Batteries account for 33 percent of the cost of manufacturing an electric vehicle. Bloomberg reports that the price of lithium-ion batteries fell by 35 percent in 2015 and is on a downward trajectory, which is predicted to make EVs as affordable as cars driven by fossil fuels by 2022 ( Bloomberg also predicts that by 2040, electric vehicles will account for 35 percent of all new vehicle sales. The major problem is that all these projects demand more cobalt than the world can currently supply. Over 95 percent of the world’s cobalt is mined as a by-product of nickel and copper.As prices of these two metals dropped in recent years, many mining companies cut production, contributing to a rising global cobalt deficit. MacQuarie Bank predicts a cobalt deficit of 885 tons in 2018, over 3,200 tons in 2019 and more than 5,300 tons in 2020. Quantum Cobalt Corp. (CSE: QBOT) (FRA: 23B) is positioning itself to take advantage of this market shortage by focusing efforts on the development of its reserves in Canada. Currently, over 50 percent of the world’s cobalt is mined in the Democratic Republic of Congo (DRC). The DRC presents mining companies with several ethical issues to contend with, including forced and child labor. The country is also affected by armed conflict and political instability, increasing the risk of investment. Consequently, several mining companies have divested their interests in the DRC and are turning to North America to develop alternative, safer and more ethical mining operations. Quantum Cobalt has concentrated its efforts in the Cobalt Belt, centered near Cobalt, Ontario. Its Nipissing Lorrain Cobalt Project has produced 16,500 pounds of cobalt and 5,500 pounds of silver in the past, and historic samples show cobalt mineralization of one to 10 inches in this mine. Past assays have shown an unusually high grade of 22 percent cobalt in this play, which is exceptional when as little as 0.5 percent is deemed economically viable. The Rabbit Cobalt Project, located 55 kilometers north of Cobalt, has a rich history of both cobalt and gold production, and returned an historic assay of 8.76 percent cobalt. Quantum Cobalt is intent on conducting mapping, prospecting and sampling focused on the mineral showing on the Rabbit Lake Occurrence. Roughly 37 kilometers south of Cobalt is the company’s Kahuna Cobalt Project, which comprises 77 claims over an area of 1,200 hectares and shows historic cobalt mineralization. The company is geared up to proceed with imminent exploration and development of these properties. On October 25, 2017, the company announced that it had deployed field crews to conduct first pass exploration on both Kahuna and Rabbit Lake properties. This preliminary work entails prospecting, geologic mapping, geochemical surveying and sampling to locate and delineate mineralized structures. Quantum Cobalt is led by an executive team of industry veterans and innovators. Its CEO, Greg Burns, has more than 22 years of experience in mineral exploration, holding several executive and operational management positions with mining and exploration companies in both Canada and Australia, including Goldstream Mining and Platinum Australia. He was previously managing director of Xenolith, subsequently Coalspur Mining Ltd and taken over by the Cline Group in 2015. Burns also headed up the mergers and acquisitions division of Capital Investment Partners, an investment bank in Western Australia. Director Jerry Huang has held several executive positions with prominent mining companies, including TNR Gold and International Lithium, which received IPO funding from the largest battery company in China. Huang has extensive knowledge and experience in drilling and exploration. Quinn Field-Dyte, director, has over 10 years of experience in the financial industry and currently serves on the boards of several companies in the mining and minerals industry that are listed on the TSX Venture Exchange. Cobalt is in short supply and is a critical element used as the cathode in lithium-ion batteries, making up 35 percent of the component mix. Current pricing of the metal is expected to soar with Bloomberg forecasting an increase to almost $100,000 per ton by 2030. A massive surge in demand for cobalt is part of that forecast, predicting global growth from the 2,000 tons used now to a startling 300,000 tons in 2030. This represents phenomenal growth in a market where Quantum Cobalt is ideally placed to meet future demand, increase revenues and develop outstanding shareholder value. Other BIG players to keep your eye on: Tesla (NASDAQ: TSLA) traded over 5,757,708 shares and closed at $312.50 yesterday. General Motors (NYSE: GM) traded over 11,234,942 shares and closed at $43.60 yesterday. Volvo (OTC: VLVLY) traded over 14,987shares and closed at $19.27 yesterday. The VW Group (OTC: VLKAY) traded over 117,742s hares and closed at $37.78 yesterday. For more information about the Quantum Cobalt please visit: Quantum Cobalt (CSE: QBOT) Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: networknewswire 11/17/2017 04:40:36 PM
1171 NetworkNewsBreaks – Global Payout, Inc.’s (GOHE) MTRAC Subsidiary Advances Cryptocurrency Token Development with Pegasus Fintech Global Payout (OTC: GOHE) said today that its MoneyTrac Technology, Inc. (“MTRAC”) subsidiary continues to make noteworthy progress with Pegasus Fintech, Inc. on their collaboration to develop a cryptocurrency token for the cannabis industry. In October, MTRAC announced the establishment of the strategic partnership to create a token that will deliver an effective option for transaction processing in the cannabis industry. The companies also aim to create a level of effective transparency in an industry where tracking transactions is a critical part of assuring compliance. MTRAC and Pegasus intend to complete all the required due diligence to meet the requirements for the launch of their anticipated regulatory compliant token offering, known as a Public Initial Blockchain Offering (“PIBCO”). “This token will do far more than just optimize the way businesses and consumers are able to process and complete basic transactions, but will create the kind of transparency that will deliver consumer safety and ensure regulatory requirements across a rapidly growing industry by making it possible to track every transaction from start to finish,” MTRAC chief operating officer Vanessa Luna stated in the news release. Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: networknewswire 11/16/2017 08:07:09 PM
1170 NetworkNewsBreaks – Algae Dynamics Corp. (ADYNF) Receives Grant from Mitacs for Cannabis Research Collaboration Innovative biotech company Algae Dynamics Corp. (OTCQB: ADYNF) this morning said the company, together with the University of Western Ontario, received project funding in the form of a C$400,000 grant from Mitacs, a Canadian not-for-profit organization. The company previously announced a research agreement with the University of Western Ontario to examine the role of specific phytochemicals in marijuana for the development of novel mental health therapies. The grant will support the collaborative project to identify and produce specific cannabinoid oil formulations with ratios that selectively target symptoms associated with these specific diseases. “This grant provides tremendous support to our sponsored research program with the University of Western Ontario and will accelerate development of nutraceutical product formulations, which is our core mission,” Algae Dynamics chairman and president Paul Ramsay stated in the news release. Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: networknewswire 11/16/2017 08:00:49 PM
1169 NetworkNewsBreaks – Skinvisible (SKVI) Inks Licensing Agreement for Distribution of Topical Cannabis Products in Select U.S. Markets Pharmaceutical solutions researcher Skinvisible Pharmaceuticals, Inc. (OTCQB: SKVI) this morning said its Ovation Science subsidiary has reached a licensing agreement with Cannabiniers, a subsidiary of Lighthouse Strategies, LLC, to distribute Skinvisible’s patented Invisicare transdermal drug-delivery technology to select markets in the United States where medical cannabis products have been legalized."We are excited to have Cannabiniers as a partner in the U.S. cannabis market. They are branding experts and have the vision and infrastructure to take Ovation's cannabis products across the United States," Skinvisible President Terry Howlett stated in the press release. "Leveraging Cannabiniers branding strategies, we have the ability to enter these markets and provide consumers with an exceptional variety of topical and transdermal products backed by science and formulated with patented technology.” Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: networknewswire 11/16/2017 07:58:13 PM
1168 NetworkNewsBreaks – Greenkraft, Inc. (GKIT) at the Forefront of Environmentally-Friendly Alternative Fuel Market Rise Building future transportation products today, Greenkraft, Inc. (OTCQB: GKIT) manufactures alternative fuel automotive products. Created to introduce clean, green, efficient, automotive products, Greenkraft is at the vanguard of green transportation introducing cost efficient and high quality alternative fuel products. A recent article highlights Greenkraft’s advantages, “With climate change becoming a growing threat and world leaders officially recognizing that carbon emissions are one of the main causes of this change, the global market for greener alternative fuels is expected to expand exponentially over the next few years. As part of worldwide efforts to generate clean energy, natural gas producers and natural gas associations are leveraging naturally occurring gases with a smaller carbon footprint than typical fossil fuels, while a growing number of companies in the field, including California-based Greenkraft, Inc. (OTCQB: GKIT), are focusing their efforts toward the development of alternative fuels and cleaner fuel systems.” Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: networknewswire 11/16/2017 07:55:16 PM
1167 NetworkNewsBreaks – HighCom Global Security, Inc. (HCGS) Receives Approval to Uplist to OTCQB HighCom Global Security (OTC: HCGS) this morning announced that it has received confirmation from the OTC Markets approving the company’s objective to upgrade from the OTC Pink sheets to the OTC-QB Venture Marketplace. HighCom will continue trading under its current symbol HCGS. "The move off the Pink sheets to a more credible and transparent platform speaks to our commitment to creating greater accountability, continued growth for HighCom Global Security and increased liquidity for our shareholders," HighCom Global Security CEO Craig Campbell stated in the news release. Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: networknewswire 11/16/2017 07:55:02 PM
1166 NetworkNewsBreaks – InMed Pharmaceuticals, Inc. (CSE: IN) (OTCQB: IMLFF) Presenting at Cannabis-Based Science Medicine Conference InMed Pharmaceuticals (CSE: IN) (OTCQB: IMLFF) this morning said that it will be presenting twice at the Biopharma Forum on 'Cannabis-Based Science & Medicine' conference. The company will present on Thursday, November 30 and Friday, December 1 at the conference taking place in Denver, CO. The company’s chief scientific officer, Dr. Sazzad Hossain, will be presenting a lecture titled "Epidermolysis to Glaucoma - Identifying Pathology Candidates for Cannabis-Based Treatments." Among other areas of interest, the lecture will shine a light on InMed’s methods of identifying disease targets for cannabinoid compound treatments. Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: networknewswire 11/16/2017 07:48:26 PM
1165 NetworkNewsBreaks – MGX Minerals Inc. (CSE: XMG) (FKT: 1MG) (OTCQB: MGXMF) Reports Near Completion of Case Lake Lithium Project MGX Minerals Inc. (CSE: XMG) (FKT: 1MG) (OTCQB: MGXMF) today reported that its joint venture partner Power Metals Corp. (“Power Metals”) is nearing the end of the 5,000 metre drill program at Case Lake Lithium. To date, forty-four holes have been finished. A decision has been made to extend this program to include five more shallow holes for a total of 49 drill holes. Also, MGX and Power Metals are planning a 2,000 metre drill program on the Northeast Dyke in January 2018. Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: networknewswire 11/16/2017 07:44:53 PM
1164 NetworkNewsBreaks – PotNetwork Holding, Inc. (POTN) Subsidiary Achieves 42% Month-Over-Month Revenue Growth in October PotNetwork Holding (OTC: POTN) this morning announced that Diamond CBD, Inc., the company’s wholly owned subsidiary, reported revenues for October of nearly $1.7 million. The strong results surpass September’s revenues by 42%. Additionally, the company recently reported third quarter revenues of $4,444,800.00, a 29% increase from the second quarter. “It’s exciting that our sales continue to strengthen. With our continuing strategy in place, we approach the end of the year with great anticipation,” PotNetwork Holding chief executive officer Richard Goulding, MD stated in the news release. Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: networknewswire 11/16/2017 07:42:17 PM
1163, Inc. (CIIX) Launches OptHemp Line Through Its Subsidiary, On (NASDAQ: AMZN) For Singles Day 2017 - Readies debut of two more new products on Amazon prior to Black Friday and Cyber Monday - Company has a strategic partnership with a Top 100 platinum level seller-partner with Amazon Marketplace - The New York Times: Alibaba generated record sales of $25.3 billion on Singles Day 2017, Inc. (OTCQB: CIIX), through its subsidiary, Inc., has launched its OptHemp product Line on (NASDAQ: AMZN) for the 2017 Singles Day promotion. It was debuted during a multi-channel campaign for both the U.S. and Chinese-American markets during the 9th annual Singles Day in China, the company announced ( The New York Times reports that for Singles Day this year Alibaba recorded sales of $25.3 billion — a record high vs. last year ( Singles Day is an annual sales event in China which is translated to “Single Sticks” holiday, celebrating being single for the mainland Chinese., Inc. is a diverse company which markets hemp-based products and health products, offers educational service to the Chinese-speaking community worldwide plus public relations and advertising support services to clients. Additionally, it has a daily video broadcast focused on cryptocurrencies from the NYSE. The San Gabriel, California-based company also has an online store in San Gabriel, California. It has formed a strategic partnership with a Top 100 platinum level seller-partner on Amazon Marketplace and has agreed to include the OptHemp product line in its catalog for resale through the Amazon channel. View some of the OptHemp products on Amazon ( CIIX also has plans to launch two new products on prior to the Black Friday and Cyber Monday shopping days. Warren Wang, CEO of CIIX, referring to the Singles Day opportunity said, “This festival has become one of the largest offline and online shopping days in the world, and as it has morphed into a global shopping holiday in the last several years; therefore, we thought it was the perfect day to launch with in advance of the holidays.” For more information, visit the company’s website at Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: networknewswire 11/16/2017 07:38:49 PM
1162 Pressure BioSciences, Inc. (PBIO) Achieves Record Quarterly Revenue Growth - Quarterly total revenue exceeds $600,000 for the first time ever - Consumable sales up 158 percent year-over-year - New Center of Excellence in Asia expected to speed expansion in China - Recently patented Ultra Shear Technology platform can be used to create or improve a wide range of medical, consumer, and industrial products, through the preparation of high quality, stable nanoemulsions Pressure BioSciences, Inc. (OTCQB: PBIO) has announced that it experienced record growth in total quarterly revenue during the third quarter of 2017, driven by continued strong instrument sales, and by a 158 percent increase in consumable sales, which is also a quarterly record ( PBIO makes and markets its proprietary pressure-based lab instruments and related products to the life sciences industry for a wide range of activities involving sample preparation, a critical part of the preparatory work for almost all scientific analysis, and for the growing nanoemulsions market based on two recently issued patents and a strategic collaboration agreement with Phasex Corporation. “We believe the revenue growth reported in the third quarter and year-to-date will not only continue in Q4 2017 and beyond, but will accelerate to an even greater rate as our new sales team begins to meet with existing and potential customers throughout the U.S. To that point, Q4 2017 Purchase Orders and Purchase Indications (90% estimated probability of closing) through early November have already exceeded products & services revenue for the full 2016 fourth quarter,” Joseph L. Damasio, Jr., VP of Finance and CFO, stated in a news release announcing the results. The company’s product gross profit margin remained steady at about 47 percent, according to the news release. PBIO’s total revenue increased from $535,334 in the third quarter of 2016 to $646,061 in the same quarter for 2017. The company also saw record quarterly growth in products and services revenue of 21 percent. Among recent highlights of the company’s operations, Pressure BioSciences set up its first Center of Excellence in Asia, which should have a marked impact on PBIO’s expansion into China. PBIO’s penetration into Europe is also expected to increase in the wake of multiple scientific presentations made throughout the continent over the past few months, some by key opinion leaders in the proteomics space. The company and Phasex Corporation recently announced a cooperative agreement on nanoemulsions technology that will help them advance the delivery of unprecedented shelf-stable mixtures to deal with demands in food, nutraceutical, pharmaceutical, cosmetic, ink, paint, and lubricant markets. The company also received the first two patents issued for its high pressure-based Ultra Shear Technology (“UST”). Pressure BioSciences held an earnings teleconference call Nov. 14 and has made a replay of the call available for the next 30 days by calling (877) 481-4010 in North America or (919) 882-2331 in other countries. The replay ID Number is 22751. “We have spent a lot of time and money over the past few years preparing for this opportunity. We believe we are ready and taking all necessary actions to grow our momentum and fully exploit the exciting growth and new markets potential that we have long envisioned,” company President and CEO Richard T. Schumacher stated in the news release. For more information, visit the company’s website at Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: networknewswire 11/16/2017 07:35:39 PM
1161 Quantum Cobalt Corp. (CSE: QBOT) (FRA: 23B) is “One to Watch” Quantum Cobalt Corp. (CSE: QBOT) (FRA: 23B) is “One to Watch” as Cobalt Prices To Rocket As Tech Giants Scramble For Supplies The Democratic Republic of Congo supplies some 60 percent of the world’s cobalt —a desperately sought after metal that is the driver of our electric vehicle (EV) boom and the fodder of battery giga-factories popping up all over the world. But this claim to fame is obscured by a much darker side of the DRC – namely that It’s in the middle of a violent uprising and it’s been using inhumane child labor to mine the precious metal. DRC’s cobalt is the ‘blood diamonds’ of this decade. Buyers are under growing pressure to give up conflict cobalt and find new sources, but the timing is tough. Major automakers and battery manufacturers are scrambling to secure supplies of cobalt. Prices are soaring, and demand can only move in one direction—up. Here’s why... [View Image:] Cobalt demand could surge 700% by 2020... and 14,900% by 2030. And smart investors are getting in to position now for the North American cobalt rush. North America has an answer to this, and there is a ‘cobalt rush’ ensuing in a place whose name says it all: Cobalt, Ontario, the site of a silver rush over a century ago. Back then, just when Cobalt, Ontario was in its silver prime, the doors of African mining opened up wide, and Cobalt was forgotten. A century later, with political instability, war and working conditions that have everyone using conflict cobalt under major scrutiny, miners are coming back to this North American venue in droves. One little-known company, Quantum Cobalt Corp. (CSE: QBOT) (FRA: 23B) has three projects in the heart of this ‘cobalt rush’ venue. It’s moving fast on exploration, with impressive past-producing mineralizations, and it’s poised to earn its place with a new type of cobalt that is safe, ethical and politically stable. Here are 5 reasons you may want to keep a close eye on Quantum Cobalt (CSE:QBOT) at a crucial moment when cobalt prices seem to be going in only one direction: #1 The New Cobalt: It’s North American Canada is already the world’s second or third biggest producer of cobalt, but it’s only been producing about 6 percent of supply, along with China. Both have been sidelined by the lure of African cobalt. But African cobalt is becoming increasingly shaky, and it’s a supply line that is no longer reliable. Canada is now ramping up exploration and development, and much of this is happening in Cobalt, Ontario. Only two years ago, according to one local geologist speaking to Canadian media, “if you had a cobalt property, you couldn’t give it away. All of a sudden, within six months, everything changed.” What’s changed is that we are using so much cobalt that it’s forced a look at the origins, and that scrutiny is leading consumers away from the DRC. Even with conflict cobalt, we’re still looking at a potential 20 percent gap in supply by 2025. So the market is betting big on new cobalt suppliers, and there’s no better place to be than Ontario’s ‘Cobalt Belt’, where Quantum Cobalt has three projects with promising exploration upside. Fortunes were made here in silver more than a century ago. Now fortunes are about to be made in cobalt. #2 Quantum Cobalt Plays, Made in North America Right in the heart of Ontario’s cobalt belt, Quantum Cobalt (CSE:QBOT) has the Nipissing Lorrain Cobalt Project, which has in the past produced over 16,500 tons of the critical metal. [View Image:] According to the company, the cobalt mineralization here is striking. Past production of five tonnes of material was reported to be an unusually high grade of 22 percent cobalt. That’s impressive when you consider that most projects are deemed valuable with as little as 0.05 percent cobalt, says CEO Greg Burns. And that’s just one project in this massive cobalt belt. The company has already launched exploration to identify targets in two other projects in the heart of this cobalt belt: Rabbit and Kahuna. The Rabbit project is just 55 kilometers north of Ontario’s prolific Cobalt district, with historic work returning an assay of 8.76 percent cobalt. The Kahuna Cobalt-Silver property, covering 77 claims over 1,200 hectares, has also seen mineralization of cobalt discovered in past work. The company has mobilized field crews to carry out first-pass exploration on both of these properties, and we expect rapid news flow on prospecting, geologic mapping, geochemical mapping, geochemical surveying and sampling to locate and delineate mineralized structures. Nearby, First Cobalt Corp. (CVE:FCC)—which pulled out of the DRC to expand in safer Canada, has past-producing assets and a market capitalization of CAD$39 million, which is expected to reach CAD$156 million pending an acquisition transaction. It all suggests that 27 Quantum, with its three cobalt projects at ground zero--may be undervalued. The past production on these properties suggests that 27 Quantum has significant exploration and development potential, and it’s coming into this game right at the edge of the cobalt cliff. And it’s got the team to back it up. #3 Big Institutional Backing for Veteran Explorers and Value-Creators Jerry Huwang, a Quantum Cobalt director, is an instrumental player in Energold Drilling Corp., a leading drilling solutions company servicing the mining and energy sectors in the Americas, Africa and Asia. Internationally recognized for social and environmental approach to drilling and operating 270 rigs in 24 countries worldwide, Jerry bring a wealth of knowledge and expertise in exploration and drilling. CEO Greg Burns, Director of Mergers and Acquisitions at Capital Investment Partners—a multi-billion-dollar fund out of Australia—has lead multiple large-scale deals, including the development of Coalspur Mines into a billion-dollar market cap company at one point. Quantum Cobalt is also backed by big institutional money, most notably that of Hayward, arguably the most respected institution in Canada. Haywood will be advising on financing and mergers and acquisitions, and it’s already a cleaning house for 4 Canadian dealers with more than CAD$5.5 billion in assets under administration. #4 Supply and Demand: Gotta Love the Math Cobalt makes up some 35 percent of the lithium-ion battery mix. And with 2 million EVs already produced, and numbers rising fast, this critical element is in short supply. [View Image:] At a price of about $60,000 per metric ton right now—cobalt is the most expensive of all battery metals. And the scramble is on for manufacturers to secure their own cobalt pipeline. Tesla leads the way, planning to pump out 500,000 EVs a year, and every other major car maker has announced a definitive shift to electric. General Motors (NYSE:GM) will launch 20 EV models by 2023 Renault will double its EV offerings in the next five years Germany’s Volkswagen plans to invest more than $24 billion in zero-emissions cars by 2030, producing 3 million EVS a year by 2025. VW Group (Volkswagen, Audi, Porsche) plans to invest a whopping $84 billion in EV development (over half going to battery production). Ford will release 13 new EV models by 2023. Daimler (which owns Mercedes-Benz) is planning 50 models by 2022. Volvo is going all electric by 2019 and anticipates selling one million EVs by 2025. Renault, Nissan and Mitsubishi, collaboratively, plan to have 12 EVs by 2022. And battery “giga” factories to support these ambitious production targets are popping up all over the world. The global lithium-ion battery market—of which cobalt is a critical element—will reach $77.42 billion by 2024. China will render supply even tighter. Right now, China is the largest consumer of cobalt in the world. China is by far the largest market for plug-ins, and it’s also the largest producer. Last year alone, 507,000 EVs and PHEVs were sold in China--a 53 percent increase from 2015, and almost double the number sold in Europe and triple the number sold in the U.S. In 2016, Chinese cobalt consumption rose by 5.3 percent year-on-year, hitting 45.900 tons—equal to over 44 percent of all global consumption. From this year to 2021, China is expected to see a 12 percent increase in cobalt consumption, on the back of EV and battery growth. #5 Ontario Loves the Supply Squeeze The shift is comprehensive. It’s complete. The only thing missing? Cobalt. And investors expect what CNBC calls “inexorable” growth in the EV industry to generate a major supply squeeze for cobalt. Everyone is scrambling to secure supply, and Cobalt, Ontario, is poised to emerge as a key player. Volkswagen has just moved to secure long-term supplies of this vital battery component, seeking a 10-year secured pipeline beginning in 2019, according to Reuters. Volkswagen alone, Reuters estimates, will need more than 150 gigawatt hours of battery capacity every year by 2025 to support its EV plans. It’s enough cobalt for just one carmaker to be labeled one of the largest procurement projects in history. In fact, the total order volume is over $58.7 billion at today’s soaring cobalt prices. Cobalt spot prices have seen a 150 percent price surge this year. According to Wood Mackenzie, demand for cobalt in EV batteries alone is expected to grow fourfold by 2020 and 11-fold by 2025. By 2021 already, the supply gap is expected to reach 12,000 tons, according to Research and Markets. So, with cobalt demand set to surge 700% by 2020... and 14,900% by 2030... The biggest beneficiaries in this wild market will be smaller, new entrants developing ethical supplies. Right now, that means North America, and Ontario’s Cobalt Belt. Sitting in the heart of this cobalt belt and surrounded by other fast-moving cobalt miners, Quantum Cobalt (CSE:QBOT) appears to be undervalued in relation to its peers, and it’s got fast-moving exploration boots on the ground. Honorable mentions: Global X Lithium ETF (NYSEARCA:LIT) has been around for 7 years, but it’s not a stunning stock story like Tesla. What it is, however, is a safer bet on lithium. There’s not as much to lose here. Year-to-date, LIT is up over 25%, and they remain steady. This fund has more than $262 million in assets, and it tracks the Solactive Global Lithium Index of companies that engage in lithium mining, refining and battery production. And it gives you exposure to Tesla, as well as to miners like FMC Corp. General Motors (NYSE:GM) is a household name. GM was born at the turn of the 20thcentury and has been a leading innovator in the automotive industry ever since. Even though it’s been surpassed in market cap by Tesla (of all companies), it is still the furthest ahead of the Big 3 car makers from Detroit in terms of EVs and self-driving cars. Recently, GM acquired Cruise Automation—a self-driving car company, and it seems determined to forge ahead even faster to play catch-up with the future. Additionally, GM is a leader in the booming electric vehicle market. As countries across the world begin to pass regulations on combustion engines, GM stands to gain significantly as an early adopter in the EV game. Fortune Minerals (TSX:FT) is another player in the cobalt space. Operating in Canada’s Northwest Territories, Fortune is eyeing status as a major Canadian producer of battery-grade cobalt chemicals--but it’s also got copper and gold bismuth upside. And it’s getting a boost from the government in terms of mining infrastructure. Fortune’s modest market cap and low buy in make it a great stock for investors looking to get a piece of the electric vehicle revolution. The company’s value has increased significantly over the past year but it hasn’t yet reached its peak. Ballard Power Systems (TSE:BLDP; NASDAQ:BLDP) Ballard develops and produces hydrogen fuel cell products for markets such as heavy-duty motive, portable power, material handling and transportation Ballard’s stock price jumped a whopping 27% in September as the company announced a new way to manufacture fuel cell batteries, reducing the need for platinum in its production process by some 80%. Ballard expects to start producing the new fuel cells at the end of this year. While Ballard looks at bit expensive compared to its peers, the stock should be on investors’ radars as this is one of the most exciting fuel cell stocks. Turquoise Hill Resources (TSX:TRQ; NYSE:TRQ) is a mid-cap Canadian mineral exploration and development company headquartered in Vancouver, British Columbia. Its focus is on the Pacific Rim where it is in the process of developing several large mines The company mines a diversified set of metals/minerals including Coal, Gold, Copper, Molybdenum, Silver, Rhenium, Uranium, Lead and Zinc. One of the fortes of Turquoise hill is its good relationship with mining giant Rio Tinto. Going forward, Turquoise’s success at the giant Oyu Tolgoi project in Mongolia will be crucial to boost its lagging share price. By: Charles Kennedy Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: networknewswire 11/16/2017 07:32:07 PM
1160 Can Blockchain Technology Revolutionize the Global Oil & Gas Industry Supply Chain? NetworkNewsWire Editorial Coverage: In some of the world’s more dynamic industries, like the oil and gas sector, companies face huge challenges on a minute-to-minute basis. Intraday fluctuations in supply and demand, paired with geopolitical changes accompanied by regulatory complexities, and the overriding need for a management system that tracks purchases and services in a volatile market, are industry-wide issues facing oil and gas producers. Just a few percentage points in one direction or the other can significantly move the needle on a company’s bottom line ( Companies determined to make a difference in their own earnings through the use of innovative, problem-solving ideas include Petroteq Energy, Inc. (TSX.V: PQE) (OTCQX: PQEFF) (Petroteq Profile), Wipro Limited (NYSE: WIT), BP p.I.c. (NYSE: BP), Advanced Micro Devices, Inc. (NASDAQ: AMD) and Riot Blockchain, Inc. (NASDAQ: RIOT). To that end, if there were a way to steady the financial needle and make that bottom line less susceptible to large-scale surprises, problem-solvers throughout the global oil and gas industry could find a greater sense of security about their supply chain needs. What if the supply chain were intelligent, transparent and able to adapt to market conditions or geopolitical pressures that affect a company’s bottom line in real time? Technological innovations are often found in the oil and gas industry, although most of those improvements have been found out in the field. There’s one innovation, however, that is still finding its way into the oil and gas sector: blockchain technology ( This decentralized, open-distributed ledger is replicated across many nodes in a peer-to-peer network, using cryptography to minimize the need for oversight, which mitigates the risk of fraud or disputes between the network’s partners. Bitcoin is the most well-known user of blockchain technology, but this is only one of many uses. Blockchain technology is particularly compelling when it comes to the industries that trade in huge economies of scale coupled with an extremely complex web of suppliers, shippers and contractors. According to a recent Deloitte industry report titled, “Blockchain: Overview of the Potential Applications for the Oil and Gas Markets and the Related Taxation,” (, the potential uses for blockchain are growing and could have significant implications for those energy exploration industries. Since the pace at which blockchain will be adopted and will consequently disrupt markets is unclear, the report suggests companies will either need to either work together to drive innovation and next-generation solutions or wait for the market to be disrupted by others. Petroteq Energy (TSX.V: PQE) (OTCQX: PQEFF) (PQEFF) is one oil and gas exploration company that refuses to wait and see what others might do, choosing instead to embrace what it sees as the many benefits of blockchain technology. On November 6, Petroteq Energy and First Bitcoin Capital Corp. (OTC: BITCF) announced a co-development agreement to create a new supply chain management platform based on blockchain technology that is specifically geared for the oil and gas industry ( Petroteq Energy is a Canadian-registered holding company engaged in the development and implementation of proprietary technologies for the environmentally safe extraction of heavy oils from oil sands, oil shale deposits, and shallow oil deposits. As part of the agreement, the two companies will share industry experience and financial and technological resources with the intention of developing and operating an enterprise-grade, blockchain-based platform that will enable oil and gas companies globally to conduct transactions. “As a company focused on the development and implementation of proprietary technologies for the environmentally safe extraction of heavy oils, we understand the importance of developing new technologies, especially blockchain-based innovations, to help companies in our industry to get competitive advantage and cost efficiency,” Petroteq CEO Alex Blyumkin said in the news release announcing the development agreement. Appropriately, Petroteq has launched a new website dedicated to the joint venture — — where problems facing the oil and gas industry are outlined and corresponding solutions are offered. PetroBloq will be the first blockchain-based platform developed “exclusively for the supply chain needs of the oil and gas sector,” providing each of the individual companies involved with cost and time savings, increased transparency, and the ability to effectively mitigate the risk of fraud and disputes amid the constantly evolving geopolitical atmosphere and subsequent market fluctuations. First Bitcoin Capital CEO Greg Rubin, an international energy products investor with vast experience in the oil and gas industries, says the challenges facing many companies require a new way of thinking. “Oil and gas companies could benefit from blockchain technology for a range of applications, from optimizing efficiency to transparency in business transactions to securely storing inventory data on the blockchain. In the last few years, the industry has struggled with price volatility and production levels, which has led to cost-cutting efforts, reduced outputs and layoffs,” notes Rubin. “These challenges have prompted many companies to rethink how they operate and to identify new ways to optimize supply chain management and transaction processing. As such, blockchain is gaining traction and broader acceptance by oil and gas industry for its potential to fundamentally change the way certain transactions are conducted.” The nature of blockchain technology makes it ideal for any kind of records management activity, including land transactions, sales of oil and gas, service contracts, sourcing contracts that often are complex and multi-jurisdictional, or joint ventures. Since all transactions are managed on a blockchain – which are, by definition, chained together and immutable – the management of a specific operation is verifiable and protective for all involved. Wipro Limited (NYSE: WIT), a leading global information technology, consulting and business process services company, recently announced it has joined with Hyperledger to design and develop open source-based blockchain solutions for enterprise-grade blockchain deployments ( Hyperledger is a global open source, collaborative effort created to advance cross-industry blockchain technologies across sectors such as finance, banking, Internet of Things, supply chain, manufacturing and technology. Another industry heavyweight with an eye on blockchain is BP p.I.c. (NYSE: BP), an integrated global oil and gas company that explores for, produces and refines oil around the world. The company operates in more than 70 countries worldwide and moves energy around the globe, serving more than 12,000 customers and is constantly using market intelligence to analyze supply and demand for its commodities. BP management also recognizes that blockchain technology provides opportunities and challenges for the energy sector, noting blockchains could transform whole industries ( Advanced Microdevices (NASDAQ: AMD) designs and produces microprocessors and low-power processor solutions for the computer, communications, and consumer electronics industries, including cutting-edge research facilities around the world. Its high-performance computing, graphics and visualization technologies are used as the building blocks for gaming, immersive platforms, and data centers. AMD graphics chips, or “GPUs,” are considered to be an important source of growth for the company’s GPU business as the commercial use of blockchain creates “long term opportunities that are interesting,” said AMD CEO Lisa Su in a Barron’s article ( Riot Blockchain (NASDAQ: RIOT) is a strategic investor and operator in the blockchain ecosystem with a primary focus on the bitcoin and Ethereum blockchains. According to the company’s website, it is a first mover on the Nasdaq as a pure play focused on blockchain technology. Formerly called Bioptix, Inc., Riot Blockchain leverages its expertise and network to build and support blockchain technology companies. It is establishing a cryptocurrency mining operation and an advisory board with technical experience intending to become a leading authority and supporter of blockchain, while providing investment exposure to the rapidly growing blockchain ecosystem ( Transportation companies like United Parcel Service are also among the numerous industries that have announced support of the blockchain technology. In joining the blockchain in Trucking Alliance (BiTA), a UPS spokeswoman said blockchain technology “has the potential to increase transparency and efficiency among shippers, carriers, brokers, consumers, vendors and other supply chain stakeholders.” The management team at Petroteq agrees, advising on PetroBloq that technology executives in oil and gas companies should consider several key areas in determining whether and how blockchain technology could be of benefit to them: Transparency and compliance – blockchain by design should enable greater transparency and efficiency. Sharing digital blockchain information in joint-operating agreements could reduce, if not eliminate, the need for reconciliations between companies and for data hubs controlled by third parties. Smart contracts – The sheer size and volume of contracts and transactions necessary to execute capital projects in oil and gas have historically caused significant reconciliation and tracing issues among contractors, subcontractors and suppliers, in addition to significant challenges in managing logistics for supplies, tracking orders and deploying inventory. Trading and third-party impacts – Blockchain technologies are beginning to disrupt and open energy trading markets. By trading physical commodities on a blockchain solution, commodity traders could benefit from increased speed of exchange, improved availability of data, and enhanced reliability and auditability as records are verified in near real-time. The oil and gas industry’s global reach is a complex one with a dizzying array of national regulations and restrictions. Simplifying and improving the supply chain is a high priority for any company centered on profitability. Exploring the benefits of blockchain technology makes not only business sense, but common sense for an industry that must constantly seek a competitive advantage in today’s ever changing economic environment. For more information on Petroteq Energy, visit Petroteq Energy, Inc. (TSX.V: PQE) (OTCQX: PQEFF) Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: networknewswire 11/16/2017 07:22:52 PM
1159 NetworkNewsBreaks – Grey Cloak Tech, Inc. (GRCK) Aims to Create CBD Marketplace with Purchase of Domain Grey Cloak Tech (OTCQB: GRCK) announced today that is has purchased the domain with an objective to create a media destination and primary marketplace for all types of hemp products, with a particular focus on cannabidiol (“CBD”) products. The company intends to make the solution to a large division in the market, as major advertising companies currently do not allow CBD products on their platforms. aspires to become the centralized, third-party marketplace available for producers and consumers of hemp products. Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: networknewswire 11/15/2017 06:36:21 PM
1158 Global Payout, Inc.’s (GOHE) MoneyTrac Subsidiary Explores Potential Strategic Partnerships in the Cannabis Banking Sector Payment solutions company Global Payout, Inc. (OTC: GOHE) this morning said that its majority-owned subsidiary, MoneyTrac Technology, Inc. (“MTRAC”), is exploring potential strategic partnership opportunities in the cannabis banking sector. In an effort to exploit a severely underserved market, MTRAC is in the process of evaluating various entities that engage in helping banking organizations become compliant with state cannabis regulations, and is highly interested in securing partnerships with established compliance financial organizations. Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: networknewswire 11/15/2017 06:33:43 PM
1157 NetworkNewsBreaks – Algae Dynamics Corp. (ADYNF) Receives $250,000 Investment to Enhance Existing University Research Programs Algae Dynamics (OTC: ADYNF), developer of unique health products infused with cannabis and algae oils, has received an investment of $250,000 from Teewinot Life Sciences Corporation, developer of biosynthetic cannabinoids. Algae Dynamics says it will use the funds for its research programs with The University of Waterloo and University of Western Ontario, as well as general administrative and compliance purposes. “These funds will allow us to continue our important university research programs and provide resources to move forward at an accelerated pace. We believe this new relationship with Teewinot will provide strategic value that will provide long term benefits for all of our key stakeholders,” Algae Dynamics chairman and President Paul Ramsay stated in the news release. Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: networknewswire 11/15/2017 06:30:15 PM
1156 NetworkNewsBreaks – SinglePoint (SING) Introduces Proprietary Bitcoin Exchange for Payment Processing in High-Risk Markets Aimed at providing a solution to address the payment processing issues of high-risk transactions in the cannabis and other industries, SinglePoint (OTC: SING) this morning announced the soft launch of a bitcoin exchange that can be utilized by any business, from convenience stores to cannabis dispensaries in the 29 legal states and District of Columbia. “We are very pleased with what we have built out and executed on with this solution. SinglePoint now has a base to continue innovating on for the cannabis payments space. Businesses are contacting us daily about payment services and with this solution we feel confident we will be on boarding many of these customers. This is just the beginning of a solution that will ultimately serve cannabis businesses much beyond payments. The overall goal is to have a fully integrated solution for businesses to manage their day-to-day operations from beginning to end,” SinglePoint President Wil Ralston stated in the press release. Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: networknewswire 11/15/2017 06:27:25 PM
1155 NetworkNewsBreaks – ABcann Global Corp. (TSX.V: ABCN) (OTCQB: ABCCF) Adds Key Individuals to Board and Executive Team ABcann Global Corp. (TSX.V: ABCN) (OTCQB: ABCCF) today announced that it has added Mr. Rick Fitzgerald to the Board of Directors and Dr. Michael Bumby to the executive team as Chief Financial Officer. Fitzgerald brings a wealth of strategic marketing and senior leadership experience in the alcoholic beverage and tobacco industries while Bumby adds extensive financial, international and capital markets experience. Paul Lucas, Chair of ABcann’s board of directors, stated, “We are pleased to welcome two outstanding individuals to ABcann and believe their domestic and global business experience will be a significant asset to the Company.” Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: networknewswire 11/15/2017 06:23:54 PM
1154 NetworkNewsBreaks – First Cobalt Corp. (TSX.V: FCC) (OTCQB: FTSSF) Commences Sampling Program to Assess Historic Cobalt Camp in Ontario Cobalt exploration and development company First Cobalt Corp. (TSX.V: FCC) (OTCQB: FTSSF) this morning said it has initiated an extensive sampling program at historic mining operations in the Cobalt Camp in Ontario. The sampling program is intended to expand the company’s understanding of the characteristics of the material for potential processing of future ores from the Cobalt Camp. First Cobalt intends to acquire a representative sample of grades across several muckpiles and examine the material. In an effort to increase the grade of feed material, ore sorting technology will also be tested on large representative samples. "In tandem with ongoing exploration, this sampling program is a cost-effective way to understand the potential of this district and one that can be repeated across our post-merger land package. Success with this program could warrant reactivating the mill and potentially the refinery to produce refined battery materials and generate early cash flow," First Cobalt president & chief executive officer Trent Mell stated in the news release. Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: networknewswire 11/15/2017 06:20:50 PM
1153 Petroteq Energy Inc. (TSX.V: PQE) (OTCQX: PQEFF) Provides Progress Update on New Oil Extraction Facility Petroteq Energy (TSX.V: PQE) (OTCQX: PQEFF), a company focused on the development and implementation of environmentally friendly heavy oil processing and extraction technologies, today announced the reconstruction of a new large-scale oil extraction facility. As part of the recent corporate restructuring, the company decided to relocate the plant from its location 10 miles from the Temple Mountain Resource Site to the TME mine site. The relocation will increase Petroteq’s production capacity from 250 to 1,000 barrels per day utilizing the company’s unique hydrocarbon extraction technology. Petroteq intends to have the relocated facility producing in February 2018. "With this new facility, we expect an increase in both efficiency and production. There is a tremendous opportunity in the development of our resources near Asphalt Ridge as we anticipate a large contingent oil sands resource base of approximately 87 million barrels of oil equivalent within that region. Over the next several weeks, we will continue to develop and respond to the needs of the new facility," Petroteq CEO Alex Blyumkin stated in the news release. Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: networknewswire 11/15/2017 06:18:06 PM
1152 Global Payout, Inc. (GOHE) Well Positioned in Smart Money Sector - Smart money invested over $17 billion in FinTech last year alone - GOHE at vanguard of explosive industry growth - Company’s Global Reserve Platform and MoneyTrac subsidiaries open vast new business opportunities The days of barter and bank drafts have long passed. Technology is in the midst of disrupting the entire financial services sector by swiftly and securely optimizing global financial transactions. Moribund financial services companies are rapidly losing market share to upstarts due to technological innovations and advancements. FinTech (financial technology) is dramatically altering traditional financial markets by delivering safer, more transparent, efficient and responsive banking services to retail consumers, businesses and market participants alike. Over $50 billion has been invested in FinTech companies since 2010 and last year alone the financial technology industry received $17.4 billion in investments ( Venture capitalists, private equity firms, savvy corporations and wealth funds are pouring enormous amounts of money into global financial technology, and smart money is seldom wrong. Already positioned to capitalize on this wave of financial innovation, Global Payout, Inc. (OTC: GOHE) delivers fully customizable comprehensive payment solutions for virtually any domestic or international organization distributing money worldwide. In business since 2009, Global Payout now services clients in four key market sectors: logistics and shipping, banking, small and mid-sized businesses, and global travel companies. Global Payout addressed the needs of these industries with its proprietary Global Reserve Platform (GRP). Powered by the Global Reserve Administrative module, the platform is a fully configurable, “banking-in-a-box” web-based platform designed to exceed the front-to-back office processing requirements of foreign exchange and international payment service providers. Global Payout is further extending its reach and impact into the global FinTech market through its majority owned subsidiaries, ISBC Holdings, Ltd. and MoneyTrac Technology, Inc. Majority control of ISBC Holdings gives Global Payout unfettered access to an international private banking structure, with cloud based banking technologies for swift and secure international financial transaction processing. MoneyTrac’s alternative banking and electronic financial solutions, which include E-Wallet and mobile apps services, open vast new found business opportunities with companies in various high-risk industries. Even though most consumers are unaware that the financial services applications they currently use count as FinTech, about a third of consumers worldwide already rely on two or more FinTech services regularly. Smart money has already placed a huge bet that the industry is set to grow exponentially and smart investors should be positioned accordingly. For more information, visit the company’s website at Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: networknewswire 11/15/2017 06:13:42 PM
1151 Blockchain to Enable Frictionless Transactions, Transparency to Ease Complexities of Global Oil & Gas Industry NetworkNewsWire Editorial Coverage: The oil and gas industry has always been a breeding ground for innovation and the adoption of new technologies, like 3-D seismic mapping and hydraulic fracturing. While a majority of such bleeding-edge tech has been implemented in field operations, back-office procedures such as supply chain management have lagged behind. Digital technologies are increasingly being used to increase profit margins via back-office enhancement, providing disruptive advantages to operators at every scale. From augmented reality and predictive financial systems to distributed open-ledgering blockchain technology, the oil and gas industry is evolving to create a major opportunity for aggressive participants such as blockchain early adopter Petroteq Energy, Inc. (TSX.V: PQE) (OTCQX: PQEFF) (FRANKFURT:MW4A) (PQEFF Profile). This is a trend that’s also successfully pursued by tech juggernauts such as Amazon, Inc. (NASDAQ: AMZN), IBM (NYSE: IBM), Microsoft Corp. (NASDAQ: MSFT) and Oracle Corp. (NYSE: ORCL). The oil and gas industry is saddled with expensive upstream exploration and development, as well as persistent downstream efficiency challenges. This inescapable reality has ignited a firestorm of activity around blockchain-enabled systems that can create real-time situational awareness and help offset associated costs and complexities. These blockchain-enabled systems can function as active transparency systems for the supply chain and are destined to further evolve into largely self-governing cognitive networks which can reduce the cost of activities such as payment transactions by up to 30 percent. But the power of cryptographically-secured and decentralized (nodal) peer-to-peer network technology like blockchain, which essentially self-monitors (while providing inherent reliability and redundancy), doesn’t stop at improving transaction handling. This technology will eventually touch every component of the increasingly complex hydrocarbon supply chain, resulting in transformative logistical advantages across key supply chain components ranging from production sites and refineries to pipelines, terminals and short-term storage facilities. This transformative capability will also help revolutionize activity at shipping and port infrastructure, as well as at the eventual points of sale. For a company like Petroteq Energy, Inc. (TSX.V: PQE) (OTCQX: PQEFF) (FRANKFURT:MW4A), known for its patented solvent/surfactant-based high-capacity bitumen extraction process for cleanly exploiting raw oil sands, the move to develop a blockchain-based platform in conjunction with First Bitcoin Capital Corp. (OTC: BITCF) is as natural as it is well-timed. Petrobloq ( is specifically designed to meet the supply chain management needs of the oil and gas sector and the unique complexities and challenges of upstream, midstream and downstream industries. Oil and gas companies face intraday fluctuations in supply and demand, as well as a constantly changing geopolitical atmosphere and increasing regulatory oversight. Paired with the underlying difficulty of exploration and production, these complexities reveal the critical nature and need for efficient supply chain management. As Petroteq and First Bitcoin understand, the supply chain must extend beyond the product that a company produces and into ancillary supply chains required to produce its product. Their Petrobloq solution is designed as an intelligent supply chain that learns market conditions and helps the user adapt to market variables – a feature that stands to benefit a wide variety of sectors. “Blockchain technology has the potential to change not only the oil and gas sector but also other areas of the global business world, leading to improved and optimized efficiency of the end-to-end business transaction processes,” First Bitcoin Capital CEO Greg Rubin explained in the press release announcing Petroteq’s $500,000 contract ( Notably, Rubin is a first-mover in the blockchain arena, which adds weight to the creation of this new blockchain-based platform. Rubin is an international energy products investor with 10 years of experience working in the Russian oil market in a variety of roles, including engineering, site planning, drilling, geophysics, and refinery operations. His international experience includes planning oil and gas infrastructure projects, oil product commerce and trading, energy, technology, refinery development and the Carbon Credit Market. Through his analysis of the commodities and financial markets worldwide, Rubin has applied his expertise in management, investor relations, market analysis and business philosophy to usher CoinQX Bitcoin and ALTcoin Exchange into future opportunities. Under his guidance, First Bitcoin Capital has chosen the Hyperledger blockchain, a product developed by the Linux Foundation-led open-source cross-industry collaborative Hyperledger Project, as the core technology for the new Petrobloq platform. First Bitcoin Capital will also build for Petroteq a smart contract system prototype on a blockchain to improve the efficiency of oil and gas supply chain management interactions. Taking advantage of distributed ledgers, the two companies will explore ways to optimize and monitor the supply chain logistics on the blockchain to automate oil and gas industry transactions. “We have begun a journey with First Bitcoin Capital to exploit the potential of this new technology. We are very pleased with the cooperation with the team and will begin to develop a first blockchain proof-of-concept. We look forward to seeing these blockchain applications applied to our business,” stated Petroteq CEO Alex Blyumkin. While blockchain technology shows incredible potential for companies like Petroteq and other oil and gas players, the success of such application can be found outside the industry entirely. Amazon (NASDAQ: AMZN) is certainly no stranger to disruptive technological innovation, having kicked open the e-commerce door in the 90s for retail, in a way that blockchain tech now seems ready to do today for a wide variety of industries. Amazon’s cloud computing unit, Amazon Web Services (AWS), continues to be the company’s most profitable and crushed Q3 expectations, with $4.58 billion in revenues on 42 percent growth. A major move to embrace blockchain last year via a collaboration with Digital Currency Group has placed AWS at the forefront of the quest to create secure and frictionless blockchain-enabled services for companies in finance, insurance and technology. IBM (NYSE:IBM) has long been at this forefront, seeking to engineer an immutable, transparent and auditable transaction platform based on blockchain. The company’s report on blockchain for the chemicals and petroleum industries deserves a closer look from investors seeking to understand how all of this will play out. The advent of IBM Blockchain, based on the Linux Foundation’s open source and cross-industry promoting Hyperledger framework, has already begun to enable fully transparent and scalable systems for a variety of industries. The potential for this sort of technology in the heavily regulated oil and gas industry, which is plagued in the international market by innumerable and varying governmental oversight requirements, really needs to be taken to heart. Microsoft (NASDAQ: MSFT) has also seen the potential of the cryptographically secure, shared, distributed ledgering technology that is blockchain. Leveraging the company’s Azure data and AI platform, Microsoft is able to offer unique off-chain data-management and analysis capabilities. A survey this year by Microsoft and Accenture (NYSE: ACN) highlighted blockchain as one of the key areas, in the next three to five years, on which some 70 percent of industry respondents intend to spend significantly more. Oracle (NYSE: ORCL) is also embracing blockchain technology, with Oracle Blockchain Cloud Services (also using Hyperledger) becoming a way for the company’s customers to easily link existing inventory and supply chain software to a secure, distributed transaction system, irrespective of where that existing software runs. The size and volume of contracts and transactions in the oil and gas industry has always created a panoply of reconciliation and tracking complications among contractors, subcontractors, and suppliers. The emergence of smart contracts enabled by blockchain technology now seems like the inevitable future. Industry regulation by governments around the world, as well as IoT (internet of things) proliferation, will continue to be driving factors for blockchain-enabled platform development in the oil and gas industry. Demand for oil is increasing steadily according to OPEC’s World Oil Outlook 2017, which recently revised its forecast for 2040 upward by 1.7 million BOPD. There is a tremendous opportunity here for companies like Petroteq, which has taken the opportunity to develop a blockchain platform for the increasingly complex logistical environment of the oil and gas industry. For more information on Petroteq Energy, visit Petroteq Energy, Inc. (TSX.V: PQE) (OTCQX: PQEFF) (FRANKFURT:MW4A) Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: networknewswire 11/15/2017 06:09:48 PM
1150 Rising Demand for Cannabis Oils Pushes Canada’s Producers into Overdrive NetworkNewsWire Editorial Coverage: Licensed cannabis producers in Canada are growing at remarkable pace, swept forward by the country’s legalization of medicinal marijuana in 2001 and impending legalization for recreational use of the plant, set for July 1, 2018. Amid demand for cannabis in various forms, oils are a significant contributor to the growth of leading producers that are keeping an eye on evolving market trends ( Key industry players such as ABcann Global Corp. (OTCQB: ABCCF) (TSX.V: ABCN) (ABCCF Profile), Emblem Cannabis, Inc. (OTC: EMMBF) (TSXV: EMC), Emerald Health Therapeutics, Inc. (OTCQX: EMHTF) (EMH: CC), OrganiGram Holdings, Inc. (OTC: OGRMF) (CVE: OGI) and Supreme Pharmaceuticals, Inc. (OTC: SPRWF) (TSXV: FIRE) are leading the industry and adjusting their strategies to include mounting consumer demand for oils. ABcann Global (OTCQB: ABCCF) (TSX.V: ABCN) is leveraging its position as a globally licensed, cost efficient producer of premium quality organic standardized medicinal cannabis to expand its product line to include cannabis oils. As one of Canada’s first licensed cannabis producers, ABcann is significantly ahead of the curve when it comes to production capacities. The company’s licensed and fully operational Vanluven Facility produces 1,000 kg annually. Construction on the company’s Kimmett facility, an industry-leading, purpose-built, world class style facility, is under contract with another 65 acres under full Abcann ownership for future expansion plans. As noted in its corporate presentation (, ABcann’s yield per square foot is 100 percent over the industry average. Pivoting off its deep roots in pharmaceutical-grade cannabis, ABcann’s wholly owned ABcann Medicinals, Inc. subsidiary in August launched CBD-Med, one of Canada’s highest legal CBD:THC (cannabidol:tetrahydrocannabinol) ratio products available on the market (, under Health Canada regulations. The launch of CBD-Med is on par with ABcann’s broader strategy to diversify its product line and capture its share of demand for cannabis oils. Products that ABcann will have available for patients are expected to include a 1-1 THC/CBD drop, a high THC dropper and a high CBD dropper. “The development of these products is in line with ABcann’s corporate strategy as a premium product provider of organic, pesticide free cannabis,” ABcann’s executive chairman stated in the press release. “As the Company continues to scale production capacity, our product line will expand as we strive to increase shareholder value through capturing a larger market share of the current global medical markets.” CBD-Med’s high CBD content is a vital differentiating factor. Although the virtues of THC have been loudly sung, many patients exhibit adverse reactions, such as short-term memory impairment, dysphoria (feeling uneasy for no apparent reason), increased levels of anxiety and even panic attacks to the cannabinoid. On the other hand, CBD is devoid of such side effects and, moreover, appears to mitigate the injurious effects of THC when taken in conjunction with it. More than half (54%) the cannabis strains on the Canadian market have a high THC-CBD ratio, with THC over 15% and CBD less than 1%. Many others (29%) have less THC but negligible amounts of CBD, with THC less than 15% and CBD below 1%. Only 14% of strains have both THC and CBD levels that exceed 5%. And just 3% of strains have less than 1% THC and more than 9% CBD, a highly prized category in which CBD-Med can be found. Emblem Cannabis, Inc. (OTC: EMMBF) (TSXV: EMC) is also strategizing for its share of the market. Earlier this month the company was granted a license to sell cannabis oils ( Late last year, Emblem was granted a supplemental license for the production of cannabis extracts. John Stewart, President of Emblem’s Pharmaceutical Division has emphasized the importance of this license to the company’s plan to provide high quality, differentiated cannabis products, in a variety of formats. Emblem plans to offer a selection of cannabis oils, including those from CBD dominant strains, THC dominant strains and strains with both CBD and THC content. The company believes cannabis oils and related formulations provide a level of consistency and dosage accuracy that cannot be achieved with dried flower. Such products also provide a method of consumption that many consumers find to be substantially more precise and convenient. Meanwhile, Emerald Health Therapeutics, Inc. (OTCQX: EMHTF) (EMH: CC), through its Emerald Health Botanicals subsidiary, as a licensed producer is already offering eight oils with varying levels of THC, THCA, CBD, and THC to CBD ratios. The product line includes the company’s recently launched CBD-25 and CBD-50 medical cannabis oils containing approximately 25 milligrams and 50 mg of CBD per milliliter ( The company believes that CBD-50 will provide a unique treatment option to doctors and patients seeking high CBD potency with minimal THC. Its management is of the opinion that CBD-50 contains the highest amount of CBD per milliliter on the ACMPR market today. Emerald Health Botanicals is now licensed to produce and sell both dried medical cannabis flower and medical cannabis oil in Canada. The subsidiary currently operates an indoor facility in Victoria, BC, and is making progress on expansion plans for a 32-acre property in Metro Vancouver and a joint venture with Village Farms that utilizes a 25-acre existing greenhouse complex in Delta, BC. Moncton, New Brunswick-based OrganiGram Holdings, Inc. (OTC: OGRMF) (CVE: OGI) in June received an upgrade to its licensed producer status (, allowing both the production and sale of cannabis oil extracts, as well as the company’s current dried medical cannabis products. Quickly acting on that approval, OrganiGram released Shubie, a pure CBD edible oil that expands its range of cannabis oil offerings. Shubie is an ethanol-extracted cannabis oil formulated in an organic sunflower oil base ( This 50ml formulation boasts 23.7 mg/ml CBD and 1.39 mg/ml THC. Like the other oils in the OrganiGram line up, Shubie was named for an iconic Atlantic Canadian waterway, the Shubenacadie River. Supreme Pharmaceuticals’ (OTC: SPRWF) (TSXV: FIRE) wholly owned 7ACRES subsidiary recently received approval from Health Canada to begin cultivation at its 30,000 square-foot flowering rooms at the company’s hybrid grow facility. The additional flowering rooms increases the size of 7ACRES’ flowering facility to 40,000 square feet. 7ACRES, and thus Supreme, also has its footing in oils via a retail partnership with Aurora Cannabis (TSX: ACB) (OTC: ACBFF). In its fourth-quarter financial results, Aurora said sales of dried medical cannabis and cannabis oils contributed $5.6 million to revenues, of which $0.4 million (7.1%) was generated in Germany and $5.2 million in Canada ( Adoption of cannabis oil continues to increase as a preferred alternative to cannabinoid consumption, providing cannabis cultivators with an unprecedented market opportunity paced by rising consumer demand. For more information on ABcann Global please visit: ABcann Global (TSX.V: ABCN) (OTCQB: ABCCF) Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: networknewswire 11/15/2017 06:04:13 PM
1149 Innovation Drives Value for Leading Cannabis Biotechs NetworkNewsWire Editorial Coverage: The medicinal cannabis market is expected to reach almost US$56 billion by 2025, according to a report by Grand View Research (, driven in part by demand for therapeutic applications of cannabinoid-based drugs for pain relief, suppression of nausea and appetite stimulation, as well as for symptomatic treatment of diseases such as glaucoma, cancer and multiple sclerosis. As an increasing volume of scientific research leans toward the efficacy of cannabis-based drugs, innovative biotech companies are advancing their R&D to develop therapeutic candidates that envelop the potential health benefits of the marijuana plant. One such company is InMed Pharmaceuticals, Inc. (CSE: IN) (OTCQB: IMLFF) (IMLFF Profile), which has several cannabinoid-based drug candidates in its pipeline. The company has also developed a proprietary and groundbreaking technology for the biosynthesis of all 90+ cannabinoids via an innovative process that enables a wide spectrum of drug development activities in-house, from drug manufacture to novel, tissue-specific formulation and all clinical and regulatory work. Though currently valued at only US$81 million, InMed’s capabilities position it among the ranks of larger biotechs with important innovations in this industry, including GW Pharmaceuticals plc (NASDAQ: GWPH), Zynerba Pharmaceuticals, Inc. (NASDAQ: ZYNE), Cara Therapeutics, Inc. (NASDAQ: CARA) and INSYS Therapeutics, Inc. (NASDAQ: INSY). Extracting cannabinoids for medicinal applications using an agriculture-based model involves a lengthy, expensive and labor-intensive process of planting, growing, harvesting, extracting and purifying. To avoid the shortcomings of an agricultural approach, several biotechs have turned to chemical processes to produce synthetic cannabinoids that can deliver consistent quality, thereby overcoming some of these concerns and increasing their prospects of gaining FDA approval. However, synthetic production can be expensive and can present potential safety issues. It is difficult to synthesize compounds that are identical to their natural counterparts, and the slightest structural variations can affect the quality and safety of the finished product. While other biotech companies instead favor partnerships with pharmaceutical raw material suppliers for their cannabinoid supply, InMed Pharmaceuticals (OTCQB: IMLFF) (CSE: IN) utilizes its proprietary biosynthesis process to manufacture any of the 90+ individual cannabinoids found in cannabis. The company’s computer-based platform bolsters this production capability by using bioinformatic algorithms to match individual cannabinoids to specific diseases, thereby identifying potential therapeutic targets for its drug development programs. InMed has been utilizing this bioinformatics approach for several years now. The platform enables the company to assess the interaction of individual cannabinoids with genes, target receptors, proteins and other criteria to measure suitability as active ingredients to target diseases. The output from the bioinformatics analysis can then be rapidly and cost-effectively validated in tissue and disease-specific in vitro and in vivo experimentation. Once confirmed in these bench-top experiments, the individual cannabinoids can then be manufactured at large scale using InMed’s proprietary biosynthesis system. In short, InMed has the ability to: Identify which cannabinoids have potential to treat specific diseases Manufacture the desired pharmaceutical-grade cannabinoid at >95% purity, with identical structures to cannabinoids found in nature, with no pesticide residue; and Formulate the cannabinoid drug candidate into a tissue-specific pharmaceutical product for advanced preclinical and clinical testing. This innovation covers a broad spectrum of the drug development process without the need to create synthetic cannabinoids or rely on the quantity and quality of other cannabis growers. InMed currently has two advanced candidates in its development pipeline. INM-750 is being developed for the treatment of epidermolysis bullosa (EB) and includes multiple cannabinoids as active ingredients. EB is a rare genetic disease with a very high unmet medical need and no currently approved treatments. INM-750 is being developed for topical application to regulate disease activity and alleviate the symptoms of EB. INM-085 is being development as a therapy for glaucoma, to be delivered as a hydrogel which can be administered once a day directly to intraocular pressure ( The estimated combined market potential of these two candidates is $6 billion per year. InMed’s innovative approach to bioinformatics and biosynthesis is groundbreaking, and the company has already filed a provisional patent to protect its cannabinoid biosynthetic process. InMed is currently working on scaling up its manufacturing capability, pivoting from the success of its proprietary laboratory-based systems. To assist with its advancing position in the market, InMed engaged as a consultant Ben Paterson, P.E., a professional engineer with extensive experience in the development of purification and manufacturing processes in the pharmaceutical industry ( Having pioneered the manufacture of cannabinoids, InMed is well positioned to maximize partnership activities by assisting biotechs and other companies – such as GW Pharmaceuticals (NASDAQ: GWPH) – with their cannabis-based drug programs. GW Pharmaceuticals is a world leader in the research and development of plant-based cannabinoid therapeutics, with a primary focus on the treatment of neurological conditions. Valued at more than US$2.5 billion, the company commercialized the world’s first cannabinoid-based drug for the treatment of spasticity caused by multiple sclerosis. Its leading development candidate is a formulation for the treatment of childhood-onset epilepsy disorders like Lennox-Gastaut syndrome and Dravet syndrome. On October 30, GW announced that it had completed its rolling submission of a new drug application to the Food and Drug Administration (FDA). The company also has several other product candidates in development for treating glioma and schizophrenia. Zynerba Pharmaceuticals (NASDAQ: ZYNE) focuses its research efforts into developing synthetic cannabinoid therapeutics using a transdermal delivery mechanism. It has two products in development: ZYN001 – a THC-based formulation for pain relief in patients with fibromyalgia and peripheral neuropathic indications, and ZYN002 – an innovative and patented gel, which contains the non-psychoactive cannabidiol (CBD) as an active ingredient, for transdermal delivery to patients with osteoarthritis and Fragile X syndrome. Zynerba’s market valuation is over US$172 million. Connecticut-based Cara Therapeutics (NASDAQ: CARA) has a market cap of US$400 million. The company has five product candidates in development, including a cannabinoid-based product, focusing on acute and chronic pain relief and the treatment of pruritus. Its proprietary formulations target the body’s peripheral nervous system. Medications that are available to treat these conditions typically have undesirable side effects, and initial trials of some of these candidates have demonstrated efficacy for both conditions without adverse reactions. The company’s most advanced opioid drug candidate, CR845, has been tested in phase 2 trials on patients undergoing laparoscopic hysterectomy or bunionectomy procedures with good results in pain reduction and the reduction of opioid-related side effects. The improvement of patient care by delivering cannabinoid-based therapies for unmet patient needs is the mission of INSYS Therapeutics’ (NASDAQ: INSY), which is valued at US$380 million. The company markets a fentanyl sublingual spray, called Subsys®, for the relief of pain associated with cancer. Since 2014, Subsys® has achieved a market share of 48 percent of prescription fentanyl products. INSYS is also developing Syndros®, a synthetic THC product for the second-line treatment of nausea induced by chemotherapy and AIDS-related weight loss. The rapidly emerging cannabis-based drug market is set for significant growth over the next few years as regulatory restrictions are eased and more companies are licensed. The innovation shown by these companies to date is what is needed to leverage market demand. For more information on InMed Pharmaceuticals, visit InMed Pharmaceuticals, Inc. (OTCQB: IMLFF) (CSE: IN) networknewswire 11/15/2017 05:58:22 PM
1148 NetworkNewsBreaks – India Globalization Capital, Inc. (NYSE: IGC) Releases Results of Annual Shareholders Meeting India Globalization Capital, Inc. (NYSE American: IGC) yesterday announced that during its 2016-2017 Annual Meeting of Shareholders on November 8, 2017, voting on Proposals Three and Four was adjourned to November 22, 2017 at 11:00 a.m. EST due to the lack of required stockholders needed. Stockholders of record on October 5, 2017 are eligible and requested by IGC to vote on these proposals that are available in the company’s proxy statement filed with the Securities and Exchange Commission ( Eligible stockholders may vote at, by dialing 800-454-8683, or by returning a properly executed proxy card to InvestorCom. The following proposals were approved at the annual meeting: (1) the election of Sudhakar Shenoy and Ram Mukunda as directors, (2) the proposal to ratify AJSH & Company as the company’s independent registered public accounting firm for the 2018 fiscal year, (3) the adoption of the company’s 2018 Omnibus Incentive Plan, (4) a non-binding advisory resolution to approve the compensation of the company’s named executive officers, and (5) approval to adjourn the meeting. Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: networknewswire 11/14/2017 06:33:47 PM
1147 NetworkNewsBreaks – Pressure BioSciences, Inc. (PBIO) Posts Q3 2017 Financial Results, Provides Business Update Pressure BioSciences (OTCQB: PBIO) (“PBI”) reported financial results for the third quarter of 2017 today, along with a business update and limited guidance regarding its expected revenue for the rest of FY 2017. Among other highlights, the company reported a record-breaking total revenue of $646,061, an increase of 21% from $535,334 in the third quarter of 2016. The company also gained increases in products & services revenue, consumable sales and grant revenue. During the quarter, PBI also completed the hiring of its new 5-person field sales team and filled its Director of Sales North America position. "We believe the revenue growth reported in the third quarter and year-to-date will not only continue in Q4 2017 and beyond, but will accelerate to an even greater rate as our new sales team begins to meet with existing and potential customers throughout the U.S.," PBI VP of finance and CFO Joseph L. Damasio, Jr. stated in the news release. Additionally, PBI will be holding a conference call to discuss the financial results today at 4:30pm EST. To join the conference, dial the North American number, (877) 407-8031 or the international number, (201) 689-8031. The verbal passcode will be “PBIO Third Quarter 2017 Financial Call.” The call will also be available for replay on the company’s website. Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: networknewswire 11/14/2017 06:30:02 PM
1146 NetworkNewsBreaks – RJD Green Inc. (RJDG) Completes Operating Software Platform for Animal Waste Management; Provides Update Regarding 2017 10K Filing Multi-division holding company RJD Green (OTC: RJDG) this morning said that its Animal Waste Management Division has completed the operating software platform that enables the computerized management of the company’s patented waste to protein process. The successful completion of this platform allows RJD Green to advance its capital procurement efforts to build and operate the first plant. The company intends to begin funding efforts upon audit approval. RJD Green’s 2017 10K filing has been delayed until this week due to a shortage in availability of management hours brought on by the chief executive officer’s unexpected knee-replacement surgery. “We are most anxious to get back on schedule with our 10K filing and audit completion. Completion of these events allows our company to move to the next important growth stage,” RJD Green CFO John Rabbitt stated in the news release. Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: networknewswire 11/14/2017 06:27:27 PM
1145 NetworkNewsBreaks –, Inc.’s (CIIX) Subsidiary Launches OptHemp Product Line on Amazon (NASDAQ: AMZN) During Singles Day Celebration, a wholly owned subsidiary of (OTCQB: CIIX), this morning said that it recently launched its OptHemp product line on (NASDAQ: AMZN) initiating a multi-channel campaign targeting both the US and Chinese-American markets. The launch is aligned during the 9th annual Singles Day Celebration and marks the company’s first use of Amazon for product sales. The launch also marks the beginning of the e-commerce marketplace initiative the company began in June through its strategic partnership with Quiverr Collective, a wholly owned subsidiary of Advantage Solutions. Per the agreement, Quiverr has agreed to include the OptHemp product line in its limited catalog for resale through the Amazon Channel. "This festival has become one the largest offline and online shopping days in the world, and as it has morphed into a global shopping holiday in the last several years; therefore, we thought it was the perfect day to launch with in advance of the holidays," Warren Wang, chief executive officer of, stated in the news release Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: networknewswire 11/14/2017 06:24:45 PM
1144 NetworkNewsBreaks – Tapinator, Inc. (TAPM) Posts Q3 2017 Financial Results Developer and publisher of mobile games, Tapinator (OTCQB: TAPM), this morning reported financial results and the filing of its quarterly report for the period ended September 30, 2017. Among other highlights, the company boasts a quarterly revenue of $850k, an increase of 37% over the previous quarter. The company launched 29 mobile games during Q3, and ended the quarter with 333 active games. Additionally, the company’s Full-Featured Games demonstrated a revenue growth of 148% for the third quarter. “Our goal in terms of our Full-Featured Games is to create franchise-type titles that have product lifespans of five to ten years. In 2018, we anticipate that (1) several titles from our existing Full-Featured portfolio will grow significantly as we optimize these titles for content and monetization; and (2) we will achieve scale with several new game launches that are currently in development,” Tapinator CEO Ilya Nikolayev stated in the news release. The quarterly report and unaudited financial statements may be found at Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: networknewswire 11/14/2017 06:20:01 PM
1143 NetworkNewsBreaks – Tapinator, Inc. (TAPM) Posts Q3 2017 Financial Results Developer and publisher of mobile games, Tapinator (OTCQB: TAPM), this morning reported financial results and the filing of its quarterly report for the period ended September 30, 2017. Among other highlights, the company boasts a quarterly revenue of $850k, an increase of 37% over the previous quarter. The company launched 29 mobile games during Q3, and ended the quarter with 333 active games. Additionally, the company’s Full-Featured Games demonstrated a revenue growth of 148% for the third quarter. “Our goal in terms of our Full-Featured Games is to create franchise-type titles that have product lifespans of five to ten years. In 2018, we anticipate that (1) several titles from our existing Full-Featured portfolio will grow significantly as we optimize these titles for content and monetization; and (2) we will achieve scale with several new game launches that are currently in development,” Tapinator CEO Ilya Nikolayev stated in the news release. The quarterly report and unaudited financial statements may be found at Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: networknewswire 11/14/2017 06:17:08 PM
1142 NetworkNewsBreaks – Patriot One Technologies, Inc. (TSX.V: PAT) (OTCQB: PTOTF) Closes $11.5M Financing; Fast-tracks Expansion & Development Plans Patriot One Technologies, Inc. (TSX.V: PAT) (OTCQB: PTOTF) this morning said it has closed on the previously announced $10 million financing with a syndicate of underwriters led by Canaccord Genuity Corp. The financing increased to $11.5 million in gross proceeds to the company at the time of closing. The company also announced the addition of two PhD engineers to run the company’s new London Development center. Additionally, the financing supports research to develop future technology such as mobile applications including wearable devices for police officers. “These funds will not only enable us to increase our base of scientific knowledge with our two new team members, but also makes Patriot One the only company in the security technology space with six of the leading global experts in microwave radar and weapons detection technologies,” Patriot One CTO Dinesh Kandanchatha stated in the news release. Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: networknewswire 11/14/2017 06:14:00 PM
1141 NetworkNewsBreaks – AppSwarm, Inc. (SWRM) Inks LOI with USA Real Estate Holding Company (USTC) to Develop Bitcoin Mobile Wallet High-tech acceleration firm in the multiplatform games industry, AppSwarm (OTC: SWRM) this morning announced that it has entered into a Letter of Intent (“LOI”) with USA Real Estate Holding Co (OTC: USTC) for the development of a smartphone based cash and bitcoin mobile wallet. Per the agreement, the companies will execute a definitive agreement within 45 days from the LOI. "The industry knowledge USA Real Estate Holdings brings to the table is very attractive to us. We look forward to a long-term relationship with USTC. This is a great opportunity for both companies, as it allows us to leverage one another's strengths and grow together," AppSwarm CEO Ron Brewer stated in the news release. Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: networknewswire 11/14/2017 06:10:58 PM
1140 Standard Lithium Ltd. (STLHF) Names New Scientific Advisory Council Member, Craig Brown P.Eng. Standard Lithium (TSX.V: SLL) (FRA: S5L) (OTCQX: STLHF) this morning announced it has appointed Craig J. Brown, P. Eng., to the company’s Scientific Advisory Council, effective immediately. Brown is a highly respected hydrometallurgical expert with over 45 years of experience in the field. Additionally, the company has initiated the first phase of test work on a new lithium-selective Ion Exchange (“IX”) resin that has been in development for numerous years by a major supplier of Li-specific IX resins. This testing expands and supplements Standard Lithium’s current testing program. “Craig brings extensive and well-respected expertise in selective ion-exchange and hydrometallurgical technologies, and will be instrumental in developing modern process flowsheets as the company continues its test work on lithium brines sourced from the company’s projects in the Bristol Dry Lake basin in the Mojave Desert of California and the Smackover Formation of Arkansas,” Standard Lithium president and COO Dr. Andy Robinson stated in the news release. Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: networknewswire 11/14/2017 06:08:06 PM
1139 Medical Cannabis Payment Solutions (REFG) Offers Cannabis Retailers Merchant Processing They Can Bank On - Medical marijuana now legal in 30 U.S. jurisdictions - Comprehensive merchant processing solution dedicated to marijuana industry - Frees customers and retailers from solely using cash The Controlled Substances Act (CSA), signed into law by President Richard Nixon in 1970, continues to cast a baneful shadow over the liberalization landscape. In the half a century since its passage, public attitudes toward cannabis have changed. A survey conducted by the respected Pew Research Center late last year found that ‘57% of U.S. adults say the use of marijuana should be made legal’ ( This is up from 12% in 1969, the year before the CSA became the law of the land. However, the Food and Drug Administration (FDA), the Drug Enforcement Agency (DEA) and the Department of Justice (DOJ) continue to buck this trend. As an example, in May 2017, Attorney General Jeff Sessions wrote Congress to record his opposition to the Rohrabacher-Farr amendment, the spending rider that bars the Justice Department from interfering with the implementation of state medical marijuana laws. Consequently, cannabis is neither fish nor fowl; it’s legal in some states but simultaneously illegal by federal law. Luckily, Medical Cannabis Payment Solutions (OTC: REFG) is offering a way out of this muddle. Through its wholly owned subsidiary, StateSourced, the company provides a proprietary, closed loop system of merchant processing for marijuana enterprises. Now marijuana dispensaries will have access to the only first-tier merchant processing operation currently available. Despite being legalized in 29 states and the District of Columbia, medical marijuana remains a Schedule 1 substance under the Controlled Substances Act of 1970. Accordingly, the members of the U.S. Federal Reserve System feel compelled to abide by the provisions of the CSA and will not charter any financial institution that serves marijuana businesses. In a seminal case late in 2015, a federal judge dismissed a lawsuit brought by the Fourth Corner Credit Union of Denver that attempted to compel the Federal Reserve to grant the credit union a ‘master account’ ( The judge agreed with the motion put forward by the Fed that ‘even transporting or transmitting funds known to have been derived from the distribution of marijuana is illegal’ and that, unlike federal prosecutors who might not enforce the law if financial institutions observed certain guidelines for dealing with the marijuana industry, a court could not ‘look the other way’. The morass resulting from the conflict between federal and state rules has created problems for the states that have legalized cannabis use, including difficulties collecting tax revenue, increased risk of serious crime, and the inability of a newly legal industry under state law to effectively engage in banking and commerce. However, Medical Cannabis Payment Solutions, which, since May 2013, has been focused on developing ancillary services for the marijuana industry, is now offering a robust, instrumental, closed loop merchant processing system. In response to the overwhelming need to have a private encrypted digital solution to serve the rapidly growing legal marijuana industry, Medical Cannabis Payment Solutions, through subsidiary StateSourced, is bringing to market the first and only first-tier merchant processing operation of its kind. The company is offering a comprehensive structure which tracks sales and tax collection and empowers businesses with an outstanding state-of-the-art client management system. Medical Cannabis Payment Solutions, which expects its first sales soon, will earn revenue by charging transaction fees of up to 5% for all financial transactions. Management believes that, currently, no other company offers a comparable completely integrated closed loop first-tier processing system for cannabis transactions. The company’s unique selling proposition is likely to be welcomed by dispensaries as the trend toward legalization of medical and recreational marijuana strengthens. For more information, visit the company’s website at Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: networknewswire 11/14/2017 06:05:19 PM
1138 First Cobalt Corp. (TSX.V: FCC) (OTCQB: FTSSF) Digs in to Fulfill World Demand for Cobalt - Surge in electric vehicles is fueling global demand for cobalt, a key ingredient in rechargeable batteries - Automakers are leading the charge in seeking a stable cobalt supply - Cobalt stocks are a bright spot for investors as the commodity’s price is projected to rise First Cobalt Corp. (TSX.V: FCC) (OTCQB: FTSSF), based in Canada, is building the largest pure-play cobalt exploration company in the world. The company is generating significant interest in the mining industry and among investors, as it holds one of only four fully-permitted cobalt extraction refineries in Canada. Upon completion of two mergers currently underway with Cobalt One Ltd. and CobalTech Mining Inc., First Cobalt will control over 10,000 hectares of prospective land and 50 historic mining operations in the region. Company management is already hosting tours of the property and explaining First Cobalt’s business strategy to mine high-grade cobalt within the historically productive sites ( First Cobalt’s current land package includes 4,300 hectares in an historic mining camp located north of Toronto and south of Cobalt, Ontario, which will grow to more than 10,000 hectares after the mergers close. Within the property lines is the Keeley-Frontier mine, along with the Drummond, Silver Banner, and Bellellen mines, which formerly produced over 3.3 million pounds of cobalt and 19.1 million ounces of silver. First Cobalt’s president and chief executive officer Trent Mell believes the mine that was shuttered many years ago is primed for rediscovery. “Finding evidence of cobalt mineralization in an area previously believed to be barren is positive news but not a surprise, as this historic camp has seen very little exploration over the past 50 years,” Mell stated last week in a press release. “We are very encouraged to see the polymetallic nature of the mineralization across the Cobalt Camp, as this suggests that a broader hydrothermal system exists beyond the historically mined veins. This is a geologically complex, target-rich land package that will require further interpretation and I am proud of our team’s progress in our first six months.” Continuing the company’s push to share its vision with investors, First Cobalt’s management team will be presenting at two conferences including the Precious Metals Summit in Zurich and the Eight Capital Battery Conference in Toronto. First Cobalt’s vice president of exploration, Dr. Frank Santaguida, is a featured speaker at the Precious Metals Summit, while Mell, a mining executive and capital markets professional with extensive international transactional experience, will speak at the Toronto conference. Due to the strong increase in cobalt demand, many industry experts are predicting the vital metal’s growth pattern will continue at an average rate of approximately five percent per annum for the next 10 years. Numerous countries around the world have stated an intention to ditch gas and diesel cars in favor of clean technology vehicles – which means the electric and hybrid vehicle industry needs a steady supply of rechargeable batteries. Accordingly, several battery makers are seeking out a steady supply of cobalt by investing in mining companies as the demand for electric vehicles soars ( First Cobalt Corp. has implemented a quality-control program and is already introducing all data from recent drilling results, geophysical and geochemical surveys, along with other pertinent data taken from the summer-fall mapping at the Keeley-Frontier property, into a 3D geological model to be used for the next phase of exploration work. Other nearby prospects in the Silver Center area have also been mapped and sampled to evaluate their potential. For more information, visit the company’s website at Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: networknewswire 11/14/2017 06:01:27 PM
1137 Biosynthesis: Making the Impossible Possible in Medicinal Cannabis NetworkNewsWire Editorial Coverage: The U.S. pharmaceutical industry is pocked with pitfalls that make it difficult for the development of cannabis-based drugs. To receive FDA approval, drug manufacturers must produce a consistent, pharmaceutical-grade product. Drug researchers with cannabis-based candidates are largely dependent on cannabis producers to access their drug raw materials. And therein lies the issue. The cannabis production sector has had its share of product recalls, and is saddled with pricey cost of commercial cultivation. The roadblocks are considerable – from legal and execution standpoints – making these efforts not quite impossible but certainly, currently, difficult. Canada-based biopharmaceutical company InMed Pharmaceuticals, Inc. (CSE: IN) (OTCQB: IMLFF) (IMLFF Profile) is taking these challenges head-on, and has broken new ground with an innovative, proprietary biosynthesis process that reliably creates pure cannabinoids. This process is capable of making any of the 90+ individual cannabinoids, under strict quality control resulting in >95% purity with no pesticides, and in a consistent fashion – factors that current plant growing methods of production cannot accomplish. Biosynthesized product with consistently high purity and quality poses a considerable advantage over the medical marijuana used by companies like CanniMed Therapeutics, Inc. (TSX: CMED) (OTC: CMMDF) (FRA: 0GB), which cultivates its own cannabis for its product pipeline. Any biotech company seeking to develop cannabinoid-based drugs could benefit from InMed’s unique approach. Currently, these biotech companies are dependent on growers like Aurora Cannabis, Inc. (TSX: ACB) (OTCQX: ACBFF), Canopy Growth Corp. (TSX: WEED) (OTC: TWMJF) and Aphria, Inc. (TSX: APH) (OTC: APHQF) to supply the raw flower or specific cannabinoid extracts needed, albeit only a few cannabinoids can be economically extracted from the plant. Such extracted product may not have the purity or consistency required to qualify as an FDA-approved pharmaceutical ingredient. The extraction techniques from plant-growing operations are subject to high fluctuation in drug concentration, as flowers from the same marijuana plant display high fluctuations in drug composition. A key factor in receiving formal drug approval from regulatory authorities includes product consistency, which may be one reason the FDA, to date, has never approved a botanically-derived marijuana drug. A few synthetic cannabinoid-based drugs have, however, been approved by the FDA (, and experts believe marijuana’s only future as a medicine in the U.S. is through its isolated, pure cannabinoid components and their synthetic counterparts. While manufacturing synthetic cannabinoids is a potential means of sidestepping the various prohibitive aspects of agricultural cannabis production, many development efforts in this area have failed. Various companies have attempted to chemically synthesize cannabinoid compounds for pharmaceutical application, but the primary restrictive factor is the difficulty of duplicating these compounds in a way that makes them identical to the naturally-occurring ones. Even a slight variation in structure can mar the efficacy and safety of synthetic cannabinoid compounds, and, as with natural sourcing, the time drain, expense and tedium of the synthetic manufacturing process (along with the large quantities of chemical waste it creates) make it a problematic enterprise. InMed Pharmaceuticals, Inc. (CSE: IN) (OTCQB: IMLFF) breakthrough biosynthesis process allows it to control the entire drug development process, in house – and without the inherent challenges of traditional agricultural cultivation methods. Biosynthesis, or the process of producing complex molecules within living organisms or cells, is currently employed in various industrial applications, including using bacteria or yeast-based systems to produce pharmaceuticals. InMed’s proprietary, pioneering approach to cannabinoid biosynthesis is truly a drug development game changer that has the potential to overcome FDA regulatory hurdles and bypass the other shortcomings associated with botanical cannabis cultivation. This process could open up several possibilities in terms of improving consistency and enabling biotechs to harness the potential of all cannabinoids. InMed employs an E. coli-based expression system for manufacturing cannabinoids that has proven internally to be much more efficient and robust than other microbial platforms, and this system enables the high-yield manufacturing of all 90+ naturally occurring cannabinoids, combining the intrinsic safety and known effectiveness of natural drug structures with the control, quality and convenience of lab-based manufacturing. Employing this exclusive process in a controlled lab setting, scientists at InMed are able to create cannabinoid compounds that are identical to those that occur naturally while eliminating problems associated with inconsistency and contamination from pesticides. Aside from inconsistency issues, another stumbling block on the botanical marijuana side is the difficulty of extracting compounds from the cannabis plant in adequate amounts and purities to pharmaceutically test them. Natural sourcing of most cannabinoid compounds is very time-consuming, difficult, expensive, inconsistent (as previously mentioned) and low-yielding. The natural sourcing process only yields about two or three cannabinoids that can be derived in adequate quantities for research, while the rest of the cannabinoid compounds only manifest themselves in trace amounts that are not accessible through extraction from plants. InMed’s biosynthesis method is can reduce the costs and time required to manufacture cannabinoid compounds that are pharmaceutically active. It is also capable of manufacturing not just some but all naturally occurring cannabinoids. InMed is effectively bringing cannabis-based drug development into a new era, shaking up the established, agriculture-based mentality of “plant, grow, harvest, extract and purify” that has long been the norm in the area of manufacturing raw cannabinoid material. The benefits of InMed’s novel approach are several and include: Substantial cost savings in comparison to traditional agricultural methods Easier path to scale-up and systems optimization Superior production, purification, quality control as compared to agricultural approaches and better structural integrity in comparison with other chemical manufacturing practices Ability to access minor cannabinoids for which plant-based extraction methods are currently economically unfeasible InMed recently announced a provisional patent application filing for this proprietary cannabinoid manufacturing biosynthesis program—the first of many to come ( Once this inaugural patent application is converted into an international Patent Cooperation Treaty (PCT) application and is pursued on a global scale in important jurisdictions, InMed will have significant commercial protection for its biosynthesis program. The company plans to actively convert this initial patent filling and subsequent provisional patents into national-stage filings in all major commercial jurisdictions. In terms of InMed’s internal drug development abilities, a recent press release from the company ( validates its capability to conduct a broad array of drug development activities that are crucial to obtaining eventual FDA approval for cannabinoid-based drugs. As discussed in the press release, InMed has successfully and consistently biosynthesized a pharmaceutical-grade cannabinoid using its novel E. coli-based system; packaged the cannabinoid as a nanoparticle; formulated a cannabinoid drug candidate into a novel, tissue-specific delivery vehicle; and confirmed drug delivery and diffusion into a target tissue. The press release announced the results of a study co-sponsored by InMed and the University of British Columbia, which is, to the company’s knowledge, the very first study to ever report hydrogel-mediated cannabinoid nanoparticle delivery to the eye. This resulted in bolstered drug uptake through the cornea and lens. Ordinary ocular formulations, like eyedrops, are almost instantly washed away following administration because of blinking. In the study, however, InMed’s proprietary hydrogel delivery method demonstrated distinctive rheological characteristics that enabled it to form a thin, uniform coating over the cornea through blinking. The gel-like “lens” that was created over the cornea held the drug in place, allowing trans-corneal absorption of the drug to occur. The drug was then able to diffuse within the eye. The overall drug delivery achieved through this hydrogel nanoparticle formulation was three times higher than the control formulation. “Importantly, this study offers further validation of InMed’s capabilities in moving the science of cannabinoid pharmaceuticals forward,” InMed President and CEO Eric A. Adams said in the press release. “Results like this, combined with our expanding patent portfolio and list of publications, on-going R&D, and renowned scientific team and collaborators demonstrates our depth of know-how and supports our trajectory to becoming an industry leader.” InMed’s drug pipeline – developed using its biosynthesis process – currently includes two products: INM-085 for the treatment of glaucoma and INM-750 for the treatment of epidermolysis bullosa. This pipeline is founded on the company’s ability to produce its own pharmaceutical-grade cannabinoids for use in its products, which enables InMed to manage the entire drug development cycle. Using bioinformatics—a proprietary, computer-based drug/disease targeting platform developed by InMed—the company is also able to identify novel cannabinoids that could be utilized in targeting specific diseases. InMed can then biosynthesize those cannabinoids for product development. This groundbreaking work is not only helping InMed toward overcoming drug approval barriers but could also have a huge impact on the efforts of other drug development companies within the cannabis sector that are striving to create cannabinoid-based therapies to treat various medical conditions. InMed’s ability to consistently manufacture pharmaceutical-grade cannabinoids demonstrates the company’s favorable cost-savings and quality aspects compared with traditional cannabis producers. While such producers are working to meet the demands of biotech companies, which are, in turn, striving to satisfy regulatory standards, these producers may face many challenges. One of the biggest marijuana growers in the world is Canopy Growth Corp. (TWMJF), which operates more than half-a-million square feet of production space. Despite its size and market domination, Canopy is dependent on significant capital and large parcels of land and is also handicapped by huge operating costs and the typical quality control issues seen with agricultural operations. Another large producer, Aurora Cannabis (TSX: ACB) (OTCQX: ACBFF) operates a 55,200-square-foot cultivation and harvesting facility in the Rocky Mountains, and the company is in the process of adding an additional 840,000 square feet across two other sites in Canada. Aurora owns a 19.9% stake in the first Australian company licensed to cultivate and conduct research on medical cannabis, and it owns a leading Germany-based wholesale importer, exporter and distributor of medical cannabis. In January 2017, Aurora announced a Type II recall of its products, as some of its marketed offerings contained “residual levels of myclobutanil and/or bifenazate that exceed any of the levels permitted in food production for these two pesticides.” Aphria (TSX: APH) (OTC: APHQF), a producer of medical-grade cannabis as well as capsules, vaporizers and orally-administered cannabis oil droppers, initiated a Type III recall of its own in March 2017 due to mislabeling of the delta-9-tetrahydrocannabidiol (THC) content of some of its products. The obstacles faced by cannabis cultivators and the subsequent disadvantages to the drug development companies that rely on them attest to the importance of the revolutionary biosynthesis process InMed has pioneered. Despite continued federal restrictions on cannabis research and cultivation in the U.S., InMed’s innovations have the potential to help biotechs clear the hurdles and create biosynthesized cannabinoid-based pharmaceutical products of unparalleled consistency and quality required to meet the FDA’s standards. Additionally, the ability to manufacture every type of cannabinoid, which is made possible by InMed’s process, is poised to be one of the most exciting innovations the medical cannabis sector has seen. For more information on InMed Pharmaceuticals, please visit: InMed Pharmaceuticals, Inc. (CSE: IN) Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: networknewswire 11/14/2017 05:57:43 PM
1136 Canadian Licensed Producers Prepare for Recreational Cannabis Legalization, Expect Significant Growth in Demand NetworkNewsWire Editorial Coverage: A momentous cultural and economic change is soon coming to Canada, as the Canadian Government has committed to legalizing recreational marijuana on July 1, 2018. Already busy with demand for medicinal marijuana – which has been legal in Canada since 2001 – licensed cultivators are ramping up their production capabilities in anticipation of a staggering surge in demand. Investors are also taking notice, in October driving average gains of 7.6% among Canadian cannabis producers ( The Canadian Government is also making preparations for the impending legalization, emphasizing cannabis education and awareness for the nation’s youth ( This focus on health and safety adds weight to the proprietary, organic and pesticide-free growing systems of ABcann Global Corp. (OTCQB: ABCCF) (TSX.V: ABCN) (ABCCF Profile), which, thanks to a hefty investment by Cannabis Wheaton Income Corp. (OTCQB: CBWTF) (TSX.V: CBW), has the capital needed to increase its supply. Other licensed producers gearing up to meet demand Maricann Group, Inc. (OTCQB: MRRCF) (MARI: CC), Emblem Corp. (OTC: EMMBF) (EMC: CC) and MedReleaf Corp. (OTC: MEDFF) (LEAF: CC). The impending legalization of marijuana for recreational use in Canada could offer licensed producers a chance to record tremendous growth in the coming months. According to a 2016 report by Deloitte, the legal Canadian marijuana market could soon be worth $18 billion annually. As for volume, Deloitte forecast annual demand for the plant at about 1.32 million pounds per year. With a highly regulated system and strict licensing requirements, the Canadian market is a safe haven for investors looking to invest in quality products and companies in a market brimming with potential. However, an overly strict licensing process restricts supply, as seen in the U.S. State of Nevada ( As a result, the Canadian government has relaxed its licensing approval process, and established growers such as ABcann Global Corp. (OTCQB: ABCCF) (TSX.V: ABCN) have a head start. Focused on producing premium quality organic standardized medicinal cannabis, ABcann has developed a proprietary computerized system to control marijuana growing, which enables it to replicate the cultivation environment of any geographical location in the world. This level of control guarantees a consistent product of superior quality that is repeatable from batch to batch, something that is demanded by both physicians and patients. The company’s innovative system uses controlled lighting, organic fertilizers and soil media to deliver natural, safe products at high yields. Through strict environmental control of temperature, humidity and water, ABcann is able to eliminate the need for pesticides, which can taint supply. Cultivation requires capital, and with $40 million in the bank, ABcann is especially well-positioned to increase its production capabilities. A hefty portion of this cash is from a $30 million with Cannabis Wheaton (OTCQB: CBWTF) (TSX.V: CBW) to fund the construction of additional ABcann production facilities. ABcann currently operates a licensed 14,500-square-foot Vanluven facility located in Napanee, Ontario, and the company is gearing up to break ground on its new 150,000-square-foot Kimmet facility in Napanee. Even with the new facility, ABcann has plenty of wiggle room, as it also owns 65 acres of land for future development with full infrastructure already in place, which will be able to accommodate another growing facility estimated at 1.2 million square feet. Experienced leadership is part of what has helped ABcann earn its stripes in the marijuana industry. At the helm of ABcann’s expansion strategies is a strong management team led by Barry Fishman, former CEO of Teva Canada, a producer of generics and specialty pharmaceuticals generating $1 billion in revenue. Fishman has a proven track record as CEO of three international companies where he exhibited his exceptional abilities in deal-making, mergers and acquisitions, and raising capital. Fishman’s experience in international markets bodes well for ABcann’s pursuit of achieving greater market share in Canada, along with growth opportunities in Germany and other parts of Western Europe, as well as in South America. Though ABcann’s current market valuation is USD$80 million (CAD$100.6+ million), the company’s capabilities place it among the ranks of larger cultivators like Maricann Group (OTCQB: MRRCF) (MARI: CC) in Langton, Ontario. Having established itself as a respected supplier of medical cannabis, the company is focusing on expanding all areas of operation, from cultivation to extraction, analytics and production, with a view to developing global markets. Health Canada recently granted to Maricann a new license to increase its production capacity by over 480 percent to 6,250,000 grams. The company also recently entered a collaboration agreement with a national provider of services to pharmacies to create a special medical cannabis program for physicians and patients. Maricann’s market cap is just more than USD$110 million. In Paris, Ontario, licensed producer Emblem Corp. (OTC: EMMBF) (EMC: CC) operates a facility that consists of six controlled indoor growing rooms, with a seventh scheduled to be added by spring 2018. As part of its expansion, Emblem is completing the construction of a 30,000-square-foot facility housing a GMP extraction laboratory as well as a value-added product and pharmaceutical production facility. In October 2017, the company entered an exclusive agreement with Canntab Therapeutics to collaborate on the preclinical formulation, development, manufacturing and commercialization of a cannabinoid-based oral sustained release formulation for the treatment of chronic pain, nausea and spasticity in patients with multiple sclerosis. Emblem’s market valuation is USD$1 million (CAD$116+ million). MedReleaf Corp. (OTC: MEDFF) (LEAF: CC) is a licensed producer, in addition to being the only ISO 9001 certified medical cannabis producer in North America. This is a quality management standard set by the International Standards Organization (ISO) and requires certified companies to adhere to strict quality control and assurance procedures. With a market cap of over USD$1.2 billion (CAD $1.5+ billion), MedReleaf has state-of-the-art marijuana growing facilities in Ontario and uses proprietary plant breeding programs and advanced cultivation methodologies. The company also conducts research and development into the therapeutic benefits of cannabis and manufactures a range of premium medical cannabis products. By forming strategic partnerships to grow their facilities, these licensed producers are well positioned to meet increased demand for Canada’s supply-hungry marijuana market, and with more than 65 acres of growth capacity, a healthy cash balance to fund upcoming construction efforts, steady sales growth, industry-leading yield rates, and an established operations team in place, ABcann is well-positioned as market leader. For more information on ABcann Global Corp., visit ABcann Global Corp. (OTCQB: ABCCF) (TSX.V: ABCN). Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: networknewswire 11/14/2017 05:52:43 PM
1135 Moxian, Inc.’s (NASDAQ: MOXC) New Strategies Behind Potential Revenue Growth, Investor Confidence - Penetrating key markets in China efficiently with paid platforms generating multiple revenue streams seen as key to its success - Joint venture with fine wine marketer and distributor Shewn International Group, based in Shanghai, seen as beginning of low-cost and quick way to gain market share, Crystal Equity Research report finds - Crystal Equity projects that the company will do $2.3 million in FY2018 Moxian, Inc. (NASDAQ: MOXC) has adopted two new dual strategies for growth: penetrating the online-to-offline (O2O) market by entering joint ventures and selling $2 million-$4 million retail businesses. The efforts to reach customers in key China markets quickly and at low cost can drive its success, Crystal Equity Research indicated in an August 2017 report ( Moxian is a Shenzhen, China-based company that is executing its strategy of converting its two platforms — Moxian+ Business and Moxian+ User apps — in the O2O market from unpaid to paid ( This would launch numerous revenue streams: transaction fees of 1% of all processing by UnionPay on these apps, subscription revenue, mobile advertising income, licensing fees, plus OEM fees. Moxian is an integrated platform operator and an early-stage company. One of the changes the company has made to its overall strategy is to target larger retail businesses, those doing $2 million to $4 million in annual sales, rather than the small and medium sized enterprises (SMEs) it focused on prior. Key to MOXC’s unique attractiveness is its built-in UnionPay digital money collection process app — a highly desired feature by merchants ( That processing also provides a revenue stream to MOXC on every transaction. UnionPay is the dominant player in China’s digital payments system, the Crystal Equity Research report indicated, and it owns 25% of the global market for credit cards with a presence in 160 countries worldwide, including the U.S. The report adds that the Shewn International Groups’ Memorandum of Understanding (MOU) signed by Moxian is critical in assessing its future performance and gaining investor confidence. “We view it as an important catalyst for valuation,” the Crystal report concluded. Shewn International Group is a distributor of fine wines. It has plans within China to market its wines in luxury apartments and other high end locations via self-pay elaborate vending machines, which keep the wines at precise temperatures. It hopes to install some 500,000 of the machines throughout the country, the report said. Under the agreement, the two companies would share technology and market strengths. For more information, visit the company’s website at Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: networknewswire 11/13/2017 06:13:42 PM
1134 NetworkNewsBreaks – Lexaria Bioscience Corp. (CSE: LXX) (OTCQB: LXRP) Covered in November ‘Let’s Toke Business’ Report Alongside Canopy Growth (TSX: WEED) Lexaria Bioscience (CSE: LXX) (OTCQB: LXRP), a biosciences company that has developed delivery technologies to improve absorption of bioactive compounds, has been featured in the November issue of ‘Let’s Toke Business.’ The report draws similarities between Lexaria and Canopy Growth (TSX: WEED), as both companies have had major breakouts on the stock market recently. The ability of Lexaria’s technology to expand into other markets was mentioned in the report, as well the possibility that non-cannabis applications could demonstrate an even greater potential. On November 9, Lexaria announced that it filed a new patent application with the U.S. Patent and Trademark Office (“USPTO”) covering the use of its DehydraTECH™ technology for the delivery of phosphodiesterase type 5 (PDE5) inhibitors. Based on existing research with cannabinoid delivery, Lexaria believes that its patented DehydraTECH™ technology will enable faster-acting treatments in many cases utilizing lower dosage quantities. Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: networknewswire 11/13/2017 06:09:57 PM
1133 NetworkNewsBreaks – Tapinator, Inc.’s (TAPM) Experienced Leaders Forge Mobile Gaming Strategy Tapinator, Inc. (OTCQB: TAPM) is producing an array of mobile gaming titles under the direction of company officers who have years of experience in the business and the understanding of trends driving the market forward. An article discussing the company reads: “Tapinator is building a large catalog of ‘Rapid-Launch Games’ that have low development costs but provide predictable returns and pairing them with a much smaller number of ‘Full-Featured Games’ that cost substantially more to develop but ‘offer massive upside potential,’ in order to establish a disciplined return-on-investment strategy.” Additionally, the company is exploring the augmented reality and virtual reality gaming industries. Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: networknewswire 11/13/2017 06:06:45 PM
1132 NetworkNewsBreaks –, Inc.’s (CIIX) Investor Relations Division Generates Substantial Revenues Market analysis company, Inc. (OTCQB: CIIX) reported a 76% year-over-year jump in operating sales in fiscal 2017. The company’s Investor Relations division boasted as the largest generator of corporate three-month revenues, contributing 62% of CIIX’s total sales for the period. An article discussing this reads: “, Inc. (OTCQB: CIIX) is driving revenue growth from its Investor Relations Division, realizing a 186% jump in sales for 1QFY2018. The first quarter revenue in FY2018 in this segment was $258,366 compared to sales of $90,312 in the first quarter of FY2017. To generate growth in FY2018, CIIX developed new products, such as multi-media and road show presentations for both brand- and company reputation- building, its 10K SEC filing reports ( In FY 2017, sales of Investor Relations had been second to those of Subscriptions.” Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: networknewswire 11/13/2017 06:03:10 PM
1131 NetworkNewsBreaks – Pressure BioSciences, Inc. (PBIO) to Host Teleconference Regarding Q3 2017 Financial Results Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI"), a leader in the development and sale of innovative solutions for the worldwide life sciences industry, announced this morning that the company will host a conference call, during which the company will provide a business update and discuss financial results for the third quarter of 2017. The call will include a presentation by the company followed by a Q&A period. The call will take place November 14 at 4:30pm EST. To join the conference, dial the North American number, (877) 407-8031 or the international number, (201) 689-8031. The verbal passcode will be “PBIO Third Quarter 2017 Financial Call.” The call will also be available for replay on the company’s website. Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: networknewswire 11/13/2017 05:59:58 PM

  • You agree not to use any obscene or offensive language to place on the discussion forum including any material that is profane, inaccurate, defamatory, false, inappropriate, threatening, hateful, constitutes junk mail or unauthorized advertising, infringes on any person’s privacy, violates copyright laws, encourages conduct that would constitute a criminal offense, give rise to civil liability, or otherwise be in violation of any local, state, national, or international law or regulation. reserves the right to remove any such content at any time without your consent.

  • To maintain relevant content, reserves the right to remove messages we assess to be inappropriate or off topic and conduct editing we identify as reasonable.  Although can delete messages, you remain solely responsible for the content of your messages, and you agree to indemnify and hold harmless with respect to any claims posted in your messages.  

  • You agree to the use of the Parents Forum for only lawful purposes and those that serve to act as an informational resource to you personally.

  • It is your responsibility to exercise your judgment in evaluating or utilizing any information shared within the discussion forum.  We encourage you to confirm the information shared in the discussion forum before undertaking any action on it.

  • We do not assume any responsibility for any websites or resources that are linked to our site or that you browse as a result of a referral you gained through a link posted on the discussion forum.

  • You can use the Contact us  link on our site to send us comments and/or criticisms regarding content posted and we welcome any feedback related to the content and administration of the discussion forum.  However, we reserve the right to make final decisions on all content posted.

  • If you have questions or concerns about the above stated Disclaimer and Terms of Use of 's Parent Forum, please Contact us . may make changes to the terms of this agreement on this site. You agree to periodically review this agreement to be aware of any such revisions. Should the revision be unacceptable to you, you agree to stop accessing this site.

  • close

    Join Now! - 100% FREE

    I agree by the terms and conditions